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ABSTRACT
The evolution of in-vitro fertilisation over the last decade has 
produced major advances in ovarian hyperstimulation, cycle -  
monitoring, oocyte retrieval and embryo transfer techniques. The 
methodology for culture of human oocytes and their fertilisation 
has been refined such that fertilisation rates of over 70%  can now  
be obtained.
Nevertheless, pregnancy rates remain disappointingly lower, with  
only 33%  being achieved by few  of the most successful groups if 
as many as three embryos are replaced.
The present study attempted to determine any relationship between  
the concentrations of prostaglandins or steroid hormones in 
follicular fluid at oocyte retrieval with the outcome of the matched 
oocyte. If a strong relationship were established this could provide 
a further means of evaluating embryo potential prior to embryo 
transfer. The importance of steroid hormones, oestradiol and 
progesterone in the follicular and luteal phases of the menstrual 
cycle is well established but the significance of prostaglandins is 
really unknown.
Preliminary studies established the methodology required for 
accurate measurement of prostaglandins in follicular fluid. This 
provided improved techniques not previously applied to follicular 
fluid prostaglandin measurement and subsequently, interesting and 
reliable information was obtained in this field.
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Studies were performed on select groups of patients in order to 
reduce the number of variables to a minimum (for instance all 
patients who had a purely mechanical barrier to conception, either 
tubal blockage, or mucus hostility with no male factor problems). 
Prostaglandins, PGE2 and PGF2<7 and oestradiol (E2) and 
progesterone (P) were measured in follicular fluid obtained at the 
time of oocyte recovery.
Follicular fluids were assigned to one of four groups depending 
upon the outcome of the matched oocytes.
1. No fertilisation
2. Fertilisation but not transferred
3. Fertilisation, transfer but no pregnancy established
4. Fertilisation, transfer and pregnancy established
Within any group there was a highly significant correlation between 
PGE2 and PGF2a levels (p<  0 .001) and a significant correlation 
between E2 and P levels (p < 0 .001) but the correlation between 
prostaglandins and steroids was poor. Progesterone levels were 
significantly lower in the unfertilised group compared to the other 
three groups (p < 0 .0 0 1 ) but no differences were shown for E2 or 
the E2:P ratio.
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No significant differences were shown among the groups in the 
actual levels of either PGE2 or PGF2„, but there were highly 
significant differences shown when the "PGE2:PGF2a ratios" were 
compared. The PGE2:PGF2a ratio fell within a much narrower range 
for the "pregnancy" group (0 .46 to 2 .00) compared with any of the 
other groups (group 1: 0 .18  to 4 .4; group 2: 0 .15  to 7 .66; group 
3: 0 .3  to 5 .91). There was a highly significant difference between 
not only the "pregnancy" group and the unfertilised group 
(p < 0 .001) but also between the "pregnancy" group and the 
fertilised but "no pregnancy" group (p < 0 .001).
Therefore for oocytes that have the potential to establish a 
pregnancy there is a well defined range for the PGE2:PGF2ff ratio. 
These studies show that measurement of PGE2 and PGF2a in 
follicular fluid could provide a valuable indicator for the selection of 
embryos with the optimal chance of establishing a pregnancy. 
Present findings have been made possible by achieving pregnancy 
rates as high as the best groups in the field and by applying 
convenient and precise methodology for the analyses of 
prostaglandins.
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SECTION 1
INTRODUCTION
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CHAPTER 1
STEROIDS AND PROSTAGLANDINS IN FOLLICULAR FLUID
1.1 PRELUDE
In vitro fertilisation (IVF) has become established over the last 
decade as a widely accepted clinical method for the treatment of 
many unrelated causes of infertility.
Since the birth of the first IVF baby in 1978 (Edwards & Steptoe, 
1979) many advances and refinements have been made to both the 
clinical and the laboratory aspects of IVF, but success rates remain 
low. The methodology of fertilisation and culture of human 
embryos have been generally standardised. Fertilisation rates are 
upwards of 70%  in the majority of established programmes (Laufer 
et al, 1986, Jones et al, 1983) but pregnancy rates remain 
considerably lower at around 33%  for the best teams if as many as 
3 embryos are replaced (Edwards, 1985).
Improved methods of assessment of the maturity and quality of 
oocytes recovered and the ability to recognise the potential of 
resultant embryos in terms of establishing a pregnancy are 
necessary.
Examination by microscopy forms the basis of present assessment 
of oocytes and embryos but this is not sufficient to produce a more 
acceptable pregnancy rate.
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Although individual oocytes are often morphologically 
indistinguishable, they behave differently in terms of fertilisation, 
cleavage and implantation of the resultant embryos. Thus better 
markers for oocyte quality are required.
Analysis of the various components of follicular fluid, readily 
obtained during the process of oocyte recovery, could be 
considered a rational approach to acquiring further information on 
the quality of recovered oocytes and their subsequent pregnancy 
potential.
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1.2 STEROID HORMONES IN FOLLICULAR FLUID
Follicular fluid is an important source of progestogens, oestrogens 
and androgens. Studies in various mammals, Bahr (1978) using 
rabbits and Goff & Henderson (1979) with rats, showed that 
changes in steroid concentrations, were indicative of the steroid 
secretory activity of the follicle. Ainsworth et al (1980) measured 
steroid hormones in porcine follicular fluid following administration 
of pregnant mare serum gonadotrophin and human chorionic 
gonadotrophin (hCG) and concluded that the ability of the follicle to 
ovulate a mature oocyte was associated with sequential changes in 
follicular fluid levels of progestins, androgens and oestrogens which 
were influenced by exposure of the developing follicle to 
gonadotrophic stimuli.
Studies on the natural cycle in humans (Fowler et al, 1977), 
showed that follicles, classified by appearance of the oocyte as 
pre-ovulatory or non-ovulatory had different hormonal 
concentrations. Pre-ovulatory follicles contained high levels of 
progesterone (P) and oestrogens (E2) but low levels of androgens in 
contrast to non-ovulatory follicles. Oocytes from non-ovulatory 
follicles could not be fertilised.
Ovarian hyperstimulation is an integral part of IVF in order to induce 
multiple follicular maturation, allowing the retrieval of more than 
one oocyte as the pregnancy rate increases with the transfer of 
multiple embryos (Sharma et al, 1988). Fowler et al (1978) 
showed that hyperstimulation of the ovaries with human 
menopausal gonadotrophin (hMG) and hCG does not appear to alter 
the relationship between the various steroid hormones.
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The earlier findings on the natural cycle were confirmed in the 
hyperstimulated cycle.
Coulam, Bustillo & Schulman (1986) first coined the term the 
"empty follicle syndrome". Tsuiki, Rose & Hung (1988) followed 
this up by comparing three IVF cycles in the same patient, of which 
tw o cycles yielded multiple oocytes and in one cycle no oocytes 
were obtained from 12 aspirated follicles. The steroid profiles of 
the follicular fluids from the empty follicle cycle showed a markedly 
increased E2 level, a markedly decreased P level and an elevated 
androgen level.
Successful fertilisation depends on the collection of oocytes which 
are mature. Oocyte maturation depends on the constituents of the 
follicular fluid (McNatty et al, 1979). During follicular maturation 
the granulosa cell undergoes a change in steroidogenesis, which is 
augmented by luteinising hormone (LH) or hCG adminstration. The 
granulosa cell shifts from being primarily an E2 producing cell to a P 
producer. Fishel, Edwards & Walters (1983) attempted to predict 
fertilisation on the basis of the steroid hormone levels in follicular 
fluid. The fertilised group showed higher P and E2 levels and lower 
androgen levels than the non fertilised group. The concentration of 
P was the most accurate predictor of successful fertilisation of an 
oocyte, with a success rate which exceeded 90% . The mean value 
of P in the fertilised group was 35 //mol/L compared to 12.5 //mol/L  
in the unfertilised group. (p < 0 .0 1 ).
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The importance of higher P concentrations for successful 
fertilisation was confirmed by Chikhaoui et al (1983) who reported 
that fertilisation only occurred when the follicular fluid P 
concentration exceeded 6 .4  //mol/L. Reinthaller et al (1987), too, 
emphasised the importance of follicular fluid P levels and successful 
fertilisation, showing a significant increase in P concentration in 
follicular fluid from fertilised oocytes (mean P 27 //mol/L) compared 
to those from unfertilised oocytes (mean P21 //mol/L). Significantly 
lower androgen levels were also found in the fertilised group.
Berger et al (1987), however showed no significant difference in 
either P or E2 levels when comparing fertilisation with non­
fertilisation.
Immature oocytes have a markedly decreased fertilisation rate. 
Botero-Ruiz et al (1984) showed that immature oocytes have a 
markedly reduced capacity to produce P in culture compared to 
mature oocytes suggesting that hCG reaches these follicles before 
they obtain a full complement of LH receptors and they are, 
therefore, unable to respond maximally to hCG stimulation.
The follicular fluid androgen/oestradiol (A/E2) ratio may be more 
important in relation to fertilisation than the P concentration 
(Chabab et al, 1986). The A/E2 ratio was significantly higher in 
their unfertilised group (mean 2.25) compared to their fertilised 
group (mean 0.9) whilst the P concentration did not show a 
significant difference. The increased A/E2 ratio in the unfertilised 
group was caused by a significant increase in follicular fluid 
androgen levels, agreeing with the findings of Fishel et al.
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Chikhaoui et al (1983), also considered a low A/E2 ratio to be 
associated with high fertilisation rates. The highest fertilisation 
rate (85% ) occurred when the A/E2 ratio did not exceed 0 .5 , the 
fertilisation rate progressively decreasing as the ratio increased. 
(A/E2 ratio more than 1, fertilisation rate =  25% ).
The ratio of E2 to P is also considered to be important. Follicular 
fluid E2 and P levels increase as the follicle matures, P increasing 
more rapidly than E2 (McNatty et al, 1975). Mature follicles thus 
have higher E2 and P concentrations and relatively lower E2/P ratios 
than immature follicles.
The major determination of the success of IVF is the stimulation of 
follicles to produce mature oocytes capable of producing normal 
pregnancies after fertilisation and culture in vitro. Botero-Ruiz et al 
(1984) evaluated the relationship between follicular fluid E2, P and 
androgen levels and successful implantation of fertilised oocytes. 
There was an association between high follicular E2 levels and 
subsequent pregnancy. Basuray et al (1988) however found no 
association between follicular fluid E2 levels and pregnancy but did 
find significantly elevated P levels in the pregnancy group and 
consequently high P:E2 ratios in this pregnancy group.
Kreiner et al (1987) analysed follicular fluid E2 and P concentrations 
in a group of 19 single follicle, single oocyte, single embryo 
transfers that resulted in 19 pregnancies. A significant correlation 
(p < 0 .0 1 ) was found between follicular fluid, E2 and the E2/P ratio 
in this group. In those patients with multiple follicles, oocyte 
maturity was associated with higher follicular fluid E2 and P 
concentrations and lower E2/P ratios compared to immature 
oocytes. Follicular immaturity was characterised by a universally 
low P and variable E2.
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These studies would suggest that follicular fluid E2 and P may be 
used as markers of oocyte viability by reflecting maturation and 
thus ability to fertilise. However no uniformity in previous findings 
has been established.
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1.3 PROSTAGLANDINS IN FOLLICULAR FLUID
Our awareness of prostaglandins began in 1935 when a lipidic acid 
was shown to be responsible for the potent biological activity of 
human seminal fluid (von Euler, 1983).
Prostaglandins are derivatives of fatty acids. The group consists of 
prostaglandins, thromboxanes, some hydroperoxy and hydroxy 
fatty acid derivatives, and leukotrienes. Although their full 
physiological role is not completely known, they exert diverse 
biological actions.
The prostaglandins are a family of naturally occurring, biologically 
active, 20 carbon unsaturated fatty acids, incorporating a 
cyclopentane ring. By convention, prostaglandins are abbreviated 
PG, with the class designated by a capital letter (A,B,E,F,G,H and 
I), followed by a number and then in some cases a Greek letter.
The letters refer to different ring structures. The number is used to 
designate the number of unsaturated bonds in the PG side -chains. 
The use of the Greek letter {a  or /3) applies only to the F series and 
refers to the hydroxyl group found at C-9. In the a-series, the 
hydroxyl group projects below the ring plane whilst in the ^-series 
the hydroxyl at C-9 is above the plane of the ring.
The predominant precursor of prostaglandins in man is arachidonic 
acid, incorporated into phospholipids in the cell membrane. Once 
formed, prostaglandins exert a very short lived effect and are 
rapidly catabolised. They are not stored preformed but are 
synthesised and secreted in response to an appropriate stimulus.
On demand, arachidonic acid is split from the cell membrane 
phospholipids by phospholipase A2 and is metabolised by one of 
tw o pathways, the lipo-oxygenase or cyclo-oxygenase.
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Cyclo-oxygenase converts arachidonic acid to unstable 
endoperoxides PGG2 and PGH2. These can isomerise to the stable 
prostaglandins - PGD2/ PGE2 and PGF2a. The E and F type 
prostaglandins, after having reached the circulation, are rapidly 
broken down in the lung and liver, through the action of a 
dehydrogenase. Consequently their blood levels are low.
The cyclo-oxygenase pathway is shown in Diagram 1 .A
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DIAGRAM 1A CYCLO-OXYGENASE ENZYME PATHWAY
Arachidonic Acid
TXA2
PGD2
cyclo-oxygenase
cyclo-oxygenase
PGH2
PGF2a
PG= Prostaglandin 
TX = Thromboxane
O
w
PGE2
OH
OH
ROH
R i, R2 = Prostaglandin side chains
Table 1 .A lists some of the reported functions of the various 
prostaglandins.
TABLE 1 .A PROSTAGLANDIN - MEDIATED EFFECTS
Site of Action 
Arterial smooth muscle 
Uterine muscle
Lower gastrointestinal 
tract
Bronchial smooth muscle 
Platelets 
Stomach 
Capillaries
Adipose tissue
The role that prostaglandins play in the process of ovulation has 
been investigated extensively. Comparisons have been made 
between ovulation and the inflammatory process, both of which 
involve prostaglandin production.
Espey (1980) proposed the hypothesis that an ovulatory surge of 
gonadotrophins induces an inflammatory reaction in mature follicles 
and this inflammatory condition leads to rupture of the ovarian 
surface. The hypothesis gives prostaglandins the central role as 
mediators of the inflammatory process and establishes a 
relationship between prostaglandins and ovarian proteolytic 
activity.
Physiological Response 
Alterations of blood pressure 
Induces labour, therapeutic 
abortion
Increases motility
Bronchospasm 
Increases coagulability 
Enhances gastric acid secretion 
Increased permeability with 
flushing
Inhibits triglyceride lipolysis
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It was suggested that this group of inflammatory mediators 
stimulated the proliferation of thecal fibroblasts and production of 
proteolytic enzymes capable of disrupting the follicle wall during 
ovulation. Yoshimura & Wallach (1987) did not dismiss an 
inflammatory like reaction causing rupture of the follicle at 
ovulation even though other hypotheses were postulated as factors 
in the process of follicular rupture. These hypotheses included an 
increase in the follicular pressure and enhanced steroidogenesis.
The absence of an increase in intrafollicular pressure preceding 
follicle rupture and the non-explosive nature of ovulation supported 
the conclusion that rupture is not a forcible phenomenon but rather 
is due to a degenerative process within the follicle wall. Yoshimura 
et al (1987) also demonstrated in the rabbit ovary that inhibition of 
steroidogenesis, oestradiol and progesterone, did not affect 
ovulation.
Parr (1975) demonstrated in rat follicles, the similarity between 
inflammation and ovulation. Changes in the follicle wall, following 
administration of hCG, were consistent with the notion that 
ovulation involved its degradation. In further support that follicle 
rupture may involve the early phase of an inflammatory process, 
indomethacin inhibition of ovulation was found to be quantitatively 
similar to the effect of indomethacin on model systems of 
inflammation in rats.
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Normal ovulation not only comprises changes in the follicle leading 
to its rupture but to at least tw o other distinct physiological 
processes: the completion of the maturation division of the oocyte 
and changes in the mode of contact between granulosa cells, 
followed by their transformation into luteal cells.
Ovulation in mammals occurs as the culmination of a sequence of 
maturational changes within the ovarian follicle in response to a co­
ordinated series of hormonal actions and interactions. Complex 
alterations including steroid and prostaglandin metabolism, 
enzymatic pathways and inflammatory mediators appear to be 
closely correlated with both the ovulatory and oocyte maturation 
processes.
The relative amounts of locally produced hormones, which act on 
the different components of the follicle simultaneously or in a 
particular sequence appear to determine the maturational stage of 
the oocyte and cumulus differentiation during the process of 
ovulation (Yoshimura et al, 1987).
The ovulatory process is controlled by the release of 
gonadotrophins from the pituitary. A direct involvement of 
prostaglandins in this process has been established by animal 
studies.
Brown & Poyser (1984) noted increased concentrations of PGE2 
and PGF2a in rat follicles at the time of ovulation with PGE2 showing 
the greater increase, some three fold more than the rise in PGF2w.
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The major role of prostaglandins in rat ovulation was also attributed 
to PGE2 by Tsafriri et al (1972). Further evidence for this was 
provided when administration of PGE2 produced follicular rupture 
where ovulation had been blocked by indomethacin.
The role of prostaglandins in oocyte maturation was unclear, as 
although indomethacin blocked follicular rupture, the entrapped 
oocytes completed their maturation division. Tsafriri et al 
concluded from this that prostaglandins must act on the ovary itself 
rather than by stimulating LH release and oocyte maturation must 
be attributed to the availability of endogenous LH. Nembutal 
blockade of LH caused non-maturation of oocytes implying that 
prostaglandins are not essential for induction of oocyte meiosis by 
LH. But it was also noted that the addition of PGE2 to cultured 
follicle enclosed oocytes induced maturation.
Administration of LH causes prostaglandin levels in follicular fluid to 
increase. Koos et al (1983) demonstrated increased prostaglandin 
levels in follicular fluid from rabbit ovaries perfused in vitro in 
response to LH. Prostaglandin levels were variable and it was 
therefore postulated that large follicles that failed to respond to LH 
with increased prostaglandin synthesis and that do not ovulate may 
be overly mature or atretic.
Munalulu, Hillier & Peddie (1987) showed the onset of ovulation to 
be closely related to the peak levels of prostaglandin synthesis. 
Yang, Marsh & Le Maire (1974) found the average levels of PGF2a 
and PGE2 to be 5 fold higher in ovulated follicles compared to non­
ovulated follicles.
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Clark, Marsh & Le Maire (1976) in rat follicles and Marsh, Yang & 
Le Maire (1974) in rabbit follicles showed a continuing increase in 
prostaglandin levels at five hours incubation following 
administration of LH.
The magnitude of the ovarian response to LH is greatest on the day 
of proestrus when follicular development is maximal (Bauminger, 
Lieberman & Lindner, 1975). Follicles explanted from proestrus 
rats before the pre-ovulatory gonadotrophin surge responded to the 
addition of LH to the culture medium with a 10-30 fold increase in 
PGE2 and a 5 fold increase in PGF2cr over a 4 hour period.
Stimulation of follicular prostaglandin accumulation was unimpaired 
during suppression of progesterone and oestrogen synthesis by 
aminoglutethimide. Steroids therefore appear to play no part in the 
mediation of the LH effect on follicular prostaglandin formation.
PGF2ff levels in rabbit follicles rise in the immediate pre-ovulatory 
period and through the time of follicular rupture but then 
progressively decline to reach near pre-ovulatory levels by 48  
hours. PGE2 levels, though, remain elevated for some time after 
ovulation before declining (Yang et al, 1974).
Similar increases in prostaglandin levels were recorded by Tsang et 
al (1979) in follicular fluid collected from the follicles of prepubertal 
gilts. These increases were maximal around the expected time of 
ovulation.
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There is a pronounced increase in follicular fluid PGF2ff levels as 
ovulation approaches but in follicles not destined to ovulate this 
increase does not occur (Ainsworth, Baker & Armstrong, 1975). 
Although these latter follicles are stimulated to grow to pre­
ovulatory size, they eventually undergo atresia. At about the time 
of ovulation, the concentration of PGF2£? in follicular fluid from 
follicles designated as pre-ovulatory reaches levels about 30  times 
greater than those from follicles which were not destined to 
ovulate.
Armstrong et al (1974) established a role for PGF2c, in rabbit 
ovulation. Microinjection into the follicle of antiserum against 
PGF2ff blocked LH induced ovulation. Intrafollicular injection of 
indomethacin under conditions in which the drug blocked ovulation 
prevented or markedly reduced the expected increase in PGF2a 
levels in the follicles.
PGF2o was shown to be involved in ovulation in the Rhesus monkey 
(Wallach et al, 1975). The monkeys were treated with hMG-hCG 
to induce ovulation together with indomethacin. Ovulation 
occurred only once in 9 cycles and then it was delayed. With the 
addition of PGF2a to the hMG-hCG and indomethacin, ovulation was 
detected in 13 of 19 cycles. This suggested that indomethacin 
inhibition of ovulation was mediated through the action of this drug 
on prostaglandin synthesis, probably at the ovarian level. 
Progesterone continued to be produced in the absence of follicle 
rupture implying that indomethacin does not locally inhibit 
luteinisation.
Thus PGF2£/ restored ovulation which was suppressed when 
indomethacin was administered together with hMG-hCG, 
suggesting that locally available PGF2ff is a pre-requisite for the 
ovulatory process.
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Rhodes et al (1985) found that indomethacin blockade of LH 
induced ovulation in "does" was associated with inhibition of both 
PGE2 and PGF2o.
The speed with which indomethacin affects follicular prostaglandin 
levels has been demonstrated by the work of Espey, Norris & 
Saphire (1986) on rabbit follicles. 2 hours after hCG 
administration, there was a significant increase in PGE2 reaching a 
peak, 10 hours after hCG, which is the expected time of ovulation. 
There was a 5.9 fold increase in PGE2 during the ovulatory process. 
PGF2a levels followed the same pattern of increase, 6 .8  fold during 
the ovulatory process.
Indomethacin significantly reduced prostaglandin levels within 5 
minutes of its administration. Ovulation was suppressed if 
indomethacin was given 2 hours pre-ovulation but if indomethacin 
was given 1 hour later, ovulation occurred. This was despite 
significant reduction in prostaglandin production.
Thus prostaglandins do not need to be produced in any significant 
amount during the hour preceding follicle rupture. This suggests 
that there may be substances other than PGE2 and PGF2ff that can 
mediate ovulation and may be less sensitive to indomethacin than 
the prostaglandins.
The conclusions drawn from these animal studies are that 
prostaglandins act at the level of the follicle. Evidence for this lies 
in measurements of prostaglandins in follicular fluid and the effect 
on prostaglandin levels of direct intra-follicular injection of 
indomethacin with consequent blockade of LH induced ovulation. 
Antisera against PGF2a: and PGE2 administered intra follicularly also 
blocks ovulation.
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As reviewed by Armstrong (1986) prostaglandins appear to play a 
major role in the pre-ovulatory processes in mammals. PGE2 and 
PGF2ct are synthesized locally in the ovarian follicle, accumulating at 
high concentrations in follicular fluid pre-ovulation. Blockade either 
by prostaglandin synthetase inhibitors or antisera to prostaglandins 
prevents ovulation without affecting most of the endocrinological 
changes and oocyte maturation.
However, although the presence of prostaglandins in pre-ovulatory 
follicles has been well documented in animals, the findings have 
not been consistent between species.
Investigations into the role played by PGE2 and PGF2ff in human 
ovulation have been aided by the advent of laparoscopy, providing 
access to ovarian follicular sampling at various stages in the 
menstrual cycle.
Darling, Jogee & Elder (1982) found increasing concentrations of 
PGF2cr in human follicular fluid leading up to ovulation with a rapid 
decline post ovulation. PGF2cr increases in a time-related sequence 
from the onset of the LH surge implying that LH plays a role in the 
follicular prostaglandin accumulation (Seibel et a l,1984).
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Lumsden et al (1986) induced follicular development with 
clomiphene followed by hCG and also found that PGF2a rose 
significantly between 0 and 36 hours after hCG. Both PGF2a and 
PGE2 showed peaks at 12 and 36 hours but unlike PGF2ef 
concentrations, increase in PGE2 between 0 and 36 hours was not 
significant. Follicles which yielded oocytes contained more PGF2a 
and PGE2 than those which did not yield oocytes. The increasing 
levels of PGF2a, 30  or more hours after the onset of the LH surge or 
the administration of hCG and associated advancing stages of 
oocyte maturation suggest prostaglandins may play a role in 
ovulation, oocyte maturation and/or the maintenance of healthy 
oocytes.
Seibel et al (1984) demonstrated a similar trend of increasing PGF2w 
concentration with resumption of meiosis and advancing stages of 
oocyte maturation. There was no similar association for PGE2 
implying that the significant changes in PGF2w do not represent cell 
death and non-specific release but rather a specific intra-follicular 
event utilising a locally active prostaglandin synthetase system.
The localisation to particular follicle components of these rises in 
prostaglandins has been investigated by Triebwasser et al (1978) in 
rabbits. Graafian follicles, 9 hours after hCG administration, were 
dissected into a follicular fluid component, a granulosa cell - oocyte 
component and a thecal cell component.
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The follicular fluid contained 4 -10  times more PGE2 and PGF2w than 
the other two components but in-vitro biosynthesis of PGE2 and 
PGF2a showed that the follicular fluid synthesised no 
prostaglandins. The cell type responsible for prostaglandin 
synthesis in the follicles appeared to be the granulosa cells or 
possibly the oocyte. As the follicular fluid represents a major site 
of accumulation of prostaglandins it may be that prostaglandins 
must pass from the granulosa cells into the antrum of the follicle 
before prostaglandins are capable of expressing their role in the 
process of ovulation.
Again interspecies differences were demonstrated, firstly by Evans 
et al (1983) and later by Ainsworth et al (1984) in studies on 
porcine pre-ovulatory follicles. Both found thecal tissue to be the 
predominant producer of PGE2 and PGF2w. The concentrations of 
both prostaglandins increased with the maturity of the oocyte. 
These findings are consistent with the concept that an increase in 
intra-follicular production of prostaglandins is a pre-requisite for 
rupture of the follicle and release of a fertilisable oocyte.
Patwardhan & Lanthier (1981) examined human pre-ovulatory 
follicles and found the concentrations of PGE2 and PGF2</ in 
follicular fluid to be higher than in theca and granulosa cells, thus 
similar to the findings of Triebwasser et al (1978) in rabbits. 
Although theca showed more capacity to form PGE2 and PGF2ct in 
vitro than the corresponding granulosa cells, exposure to 
gonadotrophins stimulated PGE2 and PGF2a formation in the 
granulosa cells and not in the theca.
Therefore, although thecal tissue showed a greater intrinsic 
capacity to form PGE2 and PGF2£/ the contribution of granulosa cells 
may be more important under acute gonadotrophin stimulation.
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The presence or absence of an oocyte within the follicle may 
determine the prostaglandin production but conflicting results have 
been produced in humans. Heinonen et al (1986) found no 
difference in prostaglandin concentrations in follicles yielding 
oocytes compared to follicles without oocytes, in cycles 
hyperstimulated with clomiphene and hMG. Conversely Lumsden 
et al (1986) showed the concentration of both PGE2 and PGF2ff to 
be significantly greater in follicles yielding oocytes, thus implying 
an association with oocyte maturation.
Lumsden's findings were supported by Jeremy et al (1986). 
Following clomiphene and hMG hyperstimulation, follicular fluid 
collected at the time of oocyte recovery contained consistently low 
concentrations of PGE2 and PGF2w when arising from non-ovulatory 
follicles.
Jeremy et al also examined the relationship between prostaglandin 
concentrations and oocyte maturity in these women and found a 
direct relationship. Mature oocyte-corona-cumulus complexes were 
derived from follicles that contained higher concentrations of PGE2 
and PGF2c, than did follicles from which immature and intermediate 
oocyte-corona-cumulus complexes were obtained. Thus there 
appears to be not only a relationship between prostaglandin 
concentrations and the process of ovulation but also with oocyte 
maturation.
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The fertilisation rate of oocytes is a reflection on oocyte maturity. 
However Chabab et al (1986) found higher concentrations of both 
PGE2 and PGF2ff in the follicular fluid from oocytes that did not 
fertilise compared to those that did fertilise. The ratio of PGE2 to 
PGF2ff was similar in both the unfertilised (n= 120) and the fertilised 
(n =  131) groups. There was a relationship between higher 
concentrations of PGE2 and PGF2a when hMG was given for ovarian 
hyperstimulation.
Reinthaller et al (1987) reported PGE2 and PGF2o levels to be similar 
in follicular fluid from both fertilised oocytes and unfertilised 
oocytes.
Follicular fluid levels of prostaglandins were measured by Chikhaoui 
et al (1983) and related to the evolution of the matured oocyte in 
terms of fertilisation in spontaneous cycles and also in cycles 
induced with clomiphene and hMG. The results from spontaneous 
cycles differed to those of induced cycles. Spontaneous cycles 
showed PGF2a concentrations in follicular fluid to be higher than 
those of PGE2. The reverse was the case in induced cycles. In 
spontaneous cycles, the follicular fluid PGE2/PGF2ct ratio correlated 
with fertilisation. Fertilisation was associated with a ratio 0 .8  or 
higher whilst fertilisation did not occur if the ratio was less or equal 
to 0 .4 .
Cristol et al (1985) measured prostaglandin levels in follicular fluid 
from induced cycles. The range of both PGE2 and PGF2a 
concentrations was too wide to assess any correlation with 
fertilisation and the PGE2:PGF2t7 ratio was similar in both favourable 
and unfavourable outcomes. But the observation made was that 
for fertilisation to occur the PGE2:PGF2„ ratio should be greater than 
0 .8 .
Dr EM Smith
Thesis 39 Chapter 1
Studies in humans, as with animal studies, have shown increasing 
concentrations of prostaglandins in follicular fluid approaching the 
time of ovulation. P G F 2a appears to play the more important role.
Contradictory evidence has been produced for prostaglandin levels 
in ovulatory and non-ovulatory follicles. The relationship between 
oocyte maturity and follicular fluid prostaglandin levels is also not 
established.
Fertilisation of oocytes is related to oocyte maturity but embryo 
quality is the vital factor for a successful outcome. The 
establishment of a pregnancy is the ultimate test of oocyte/embryo 
quality but thus far no consistent association has been made 
between follicular fluid prostaglandin levels and pregnancy outcome 
for the matched oocyte.
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1.4 METHODOLOGY FOR PROSTAGLANDIN ANALYSIS
Prostaglandins are measured by radioimmunoassay, this being the 
most sensitive analytical method. The method combines the 
sensitivity of radioactive measurements and the specificity of the 
antigen-antibody reaction (Felber, 1982).
The radio-immunoassay method is a competitive binding technique 
and was devised originally for the measurement of insulin (Yalow & 
Berson, 1960). A radioactive tracer competes for antibody sites 
with the compound to be measured in radioimmunoassay. The 
amount of tracer bound to the antibodies is inversely proportional 
to the amount of compound being measured.
i
In fact, the system is based on the interrelationship between three 
substances: the antibody, the unlabelled and the labelled antigen, 
which are in equilibrium in the incubation medium. (Diagram 1.B)
DIAGRAM 1.B
BASIS OF RADIOIMMUNOASSAY
Ag Ag *
+
Ab (limited concentration)
AgAb
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A brief synopsis of the methodology used by other authors to 
measure prostaglandins is given in Table 1.B.
TABLE 1.B
METHODOLOGY OF VARIOUS AUTHORS 
IN MEASUREMENT OF PROSTAGLANDINS
AUTHOR MATERIAL EXTRACTION CHROMATO- RIA
& YEAR ANALYSED METHOD GRAPHY
Ainsworth Pig Follicular Ethanol No Yes
1975  Fluid
Armstrong Rabbit Crushed Ethanol No Yes
19 7 4  Follicles
Bauminger Rat-Homogenised Ether No Yes
1975  Follicles
Brown Rat Homogenised Ethylacetate Silicic Gas
1975  Follicles Acid Chrom
Mass Spec
Chabab Human No No Yes
198 6  Follicular Fluid
Clark Rat Homogenised Ethylacetate Silicic Yes
19 7 6  Follicles Isopropanol Acid
Darling Human No No Yes
1982  Follicular Fluid
Espey Rabbit No No Yes
19 8 4  Homogenised
Follicles
Evans Pig Granulosa No No Yes
1983  Cells
Heinonen Human Isopropanol XAD -2 Yes
1 9 8 6  Follicular fluid Ethyl-acetate Resin
Jeremy Human Ethanol XAD -2 Yes
198 7  Follicular fluid Resin
Koos Rabbit Ethylacetate No Yes
1983  Follicular fluid
Lumsden Human No No Methyloxim e
19 8 6  Follicular fluid Derivatives
Yes
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AUTHOR  
& YEAR
MATERIAL
ANALYSED
EXTRACTION
METHOD
CHROM ATO­
GRAPHY
RIA
Marsh
19 7 4
Rabbit
Homogenised
Follicles
Ethylacetate
Acid
Silicic Yes
Patwardhan
1981
Human
Homogenised
Follicles
Ethylacetate
Isopropanol
Micro- 
Silicic Acid
Yes
Reinthaller
1987
Human
Follicular Fluid
Ethylacetate Slurry of 
BIO-SILA
Yes
Rhodes
1985
Rabbit
Follicular Fluid
No No Yes
Seibel
1984
Human
Follicular Fluid
No No Yes
Triebwasser
1978
Rabbit
Follicular Fluid
No No Yes
Tsang
1979
Pig Follicular 
Fluid
Ethanol No Yes
Yang
1 9 7 4
Rabbit
Homogenised
Follicles
No No Yes
Table 1 .B clearly demonstrates that radioimmunoassay is the 
accepted method for measurement of prostaglandins but that there 
is no overall agreement on sample preparation methods prior to 
assay.
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1.5 AIM OF THE THESIS
Animal and human studies have indicated a role for prostaglandins in the 
process of ovulation. The relationship between follicular fluid 
prostaglandin levels and the outcome of the matched oocyte remains 
unclear in both animal and human studies. The main aim of these studies 
was "to establish the relationship between prostaglandins and oocyte 
potential" at the time of human IVF oocyte recovery.
Reliable methods for preparation of samples and the establishment of 
sound radioimmunoassays for PGE2 and PGF2ff were to be developed.
The studies would initially consider all follicular fluids for analysis and then 
be refined to include only those from patients where there was a 
mechanical indication for IVF. Patients with evidence of endometriosis, a 
male factor problem or unexplained infertility would be excluded from the 
in depth analysis. Any differences in the concentrations of PGE2 and 
PGF2a in follicular fluid would also be studied for oocyte containing and 
non-oocyte containing follicles. Oocyte outcomes evaluated would be the 
subsequent fertilisation, or non fertilisation, cleavage rates and the grade 
of resultant embryos.
PGE2 and PGF2a and the steroid hormones, E2 and P, would be measured 
in follicular fluid. Steroid results would also be analysed in relation to the 
outcome of the matched oocytes. Any correlation between steroid and 
prostaglandin levels would be investigated.
The pregnancy rate achieved during the programme was such that 'the 
pregnancy outcome of embryos could be assessed in relation to the above 
biochemical parameters'.
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CHAPTER 2
IN VITRO FERTILISATION: GENERAL CONSIDERATIONS
2.1 OVARIAN HYPERSTIMULATION
Adequate ovarian stimulation is a pre-requisite for IVF. Multiple 
follicles must be stimulated to guarantee a sufficient number of 
recovered oocytes for the transfer of around three good quality 
embryos to achieve the highest pregnancy rates. The stimulation 
regime administered must provide the response required to meet 
these objectives.
'Clomiphene citrate (CC) and human menopausal gonadotrophin 
(hMG)' was considered to be the conventional treatment to 
stimulate the ovaries for in-vitro fertilisation. Many patients on this 
regime display an endogenous LH surge and this must be monitored 
continually to maintain the highest chances of success (Edwards,
1985).
Endogenous LH surges, if strong enough, may cause spontaneous 
ovulation and thus loss of oocytes or if weaker, and therefore more 
difficult to detect, may result in follicles that are luteinised at the 
time of oocyte recovery. This luteinisation causes abnormal 
fertilisation and embryonic growth with dispermic oocytes and 
fragmenting embryos.
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Lejeune et al (1986) reported a significant difference in the number 
of oocytes retrieved after a spontaneous LH surge compared with 
the number retrieved if hCG was given, 57%  of follicles yielding 
oocytes after an LH surge compared with 71 % after hCG. The 
pregnancy rate was also significantly lower after an LH surge. 
Cycles, with a spontaneous LH surge were characterised by 
impaired follicular growth and E2 secretion, dysmaturity of the 
oocyte - cumulus complex and reduced P levels in the early luteal 
phase.
Wang et al (1987) observed the same adverse effects. There was 
a significant reduction in the number of oocytes recovered and in 
turn the number of embryos transferred when an LH surge occurred 
compared with hCG administration with no LH surge occurring. 
These adverse effects combined with the difficulties both to 
patients and staff of continual monitoring for endogenous LH 
surges, encouraged us to seek an alternative stimulation regime.
Luteinising hormone releasing hormone analogues (LHRH-A) given 
in excess abolish endogenous LH production by inducing 
endogenous hypogonadotrophism, which can be exploited by 
induction of follicular growth with exogenous gonadotrophins 
(Fleming & Coutts, 1986). Therefore cycles do not have to be 
cancelled because of premature luteinisation of follicles and can be 
more easily monitored and controlled.
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Serafini et al (1988), reported a significant improvement using the 
LHRH-A, leuprolide acetate and hMG, in patients who previously 
had responded poorly to CC and hMG. Oocyte recovery was 
successful in only 17.5%  of these patients when stimulated with 
CC and hMG compared to 92 .6%  when leuprolide acetate and hMG 
were used.
The number of oocytes recovered is also significantly improved 
using an LHRH-A and gonadotrophins. Rutherford et al (1988) 
compared results in women receiving CC and hMG and women 
receiving the LHRH-A buserelin and hMG. The mean number of 
oocytes recovered was significantly higher with buserelin and hMG,
9.5 compared to 5.5 with CC and hMG. In addition the mean 
number of embryos obtained was significantly higher with buserelin 
and hMG, 4 .3  compared to 2 .9  with CC and hMG.
Neveu et al (1987) found similar improvements when comparing 
the use of buserelin and follicle stimulating hormone (FSH) with  
FSH alone. The number of oocytes recovered was significantly 
higher with buserelin and FSH.
Both Rutherford et al and Neveu et al reported higher pregnancy 
rates in patients receiving buserelin and gonadotrophins.
Thus buserelin in combination with gonadotrophins produces good 
quality fertilisable oocytes allowing a higher degree of selection of 
those embryos suitable for transfer. This was the regime adopted 
for ovarian stimulation in this programme.
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2.2  CYCLE MONITORING
Ultrasound (U/S) measurement of follicular diameter and serial 
serum oestradiol levels are the standard monitoring modalities in 
IVF. Scanning can be performed transabdominally or 
transvaginally.
The success of IVF depends on the collection of mature, fertilisable 
oocytes. Therefore accurate monitoring methods for follicular 
development are essential to ensure the optimal timing of oocyte 
recovery.
All cycles are monitored biochemically, serum oestradiol 
concentrations being the most reliable steroid hormone indicator of 
an appropriate ovarian response.
Hackeloer et al (1979) showed a good correlation between 
peripheral serum E2 levels and U/S measurement of follicular 
diameter in the unstimulated cycle, but Ritchie (1985) showed a 
deteriorating correlation with increasing numbers of stimulated 
follicles. Nevertheless, it is generally accepted that knowledge of 
the number of follicles is necessary for adequate interpretation of E2 
levels and it is not.the absolute value of E2 that is a good predictor 
of success (Jones et al, 1983).
Transvaginal U/S provides an improved quality of image over 
transabdominal U/S. This is attributed to the relatively short 
distance of 2-4cm between the vaginal vault and the ovaries 
compared to that between the abdominal wall and the ovaries with 
the intervening full bladder necessary for abdominal scanning.
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Yee et al (1987) compared transabdominal and transvaginal U/S 
measurements with the findings at laparoscopy. The transvaginal 
route produced increased visualisation and resolution of follicles 
compared with the transabdominal route.
These are the reasons for this programme changing from 
transabdominal ultrasound monitoring to transvaginal monitoring 
during the first year of operation.
Dr EM Smith
Thesis 49 Chapter 2
2.3 OOCYTE RECOVERY
When IVF became established as a recognised treatment for 
various forms of infertility, laparoscopy was the only method used 
for oocyte recovery. This was the technique developed by Steptoe 
& Edwards (1979).
Ultrasound - guided methods were later developed for patients with  
limited ovarian access and found to provide a viable alternative to 
laparoscopy (Lenz, Leeton & Renou, 1987, Wikland et al, 1987). 
Excellent results for the transabdominal, transvesical approach have 
been reported by Lewin et al (1986) and Riddle et al (1987).
Feichtinger & Kemeter (1986) and Wikland et al (1987) reported 
their results using the transvaginal route. Oocyte recovery rates 
were at least as good as other methods of recovery but with 
substantial benefits to patients.
General anaesthesia and a prolonged pneumoperitoneum as 
required for laparoscopic recovery were avoided. Thus the 
recovery time for the patient and the length of hospitalisation were 
shortened. In addition, Boyers et al (1987) has suggested a 
decreased fertilisation rate and Hayes et al (1987) a detrimental 
effect on cleavage associated with either general anaesthesia or 
C 0 2 pneumoperitoneum.
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The transvaginal route confers advantages over other ultrasound 
routes in the avoidance of a full bladder, the high acceptance rate, 
light sedation with ovarian access rarely a problem, the short 
puncturing distance and a decreased length of time for oocyte 
recovery (Janssen-Caspers et al, 1988). (Diagram 2 .A)
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2 .4  LUTEAL PHASE
Luteal phase support following ovarian hyperstimulation and 
follicular aspiration for IVF has been the subject of great debate. 
Adequate production of progesterone by the corpus luteum is 
necessary for implantation of a pregnancy and its early 
maintenance (Csapo et al, 1972). It has been suggested that 
follicular aspiration, by removing granulosa cells during oocyte 
recovery, may cause deficiency in luteal phase function or, 
alternatively, that the ovulatory dose of hCG may provide 
inadequate stimulation of the corpora lutea. Yet it has been shown 
that follicular aspiration does not lead to lower P levels (Varygas, 
Kletzky & Marrs, 1986) and, because of the presence of multiple 
corpora lutea, progesterone levels after in-vitro fertilisation/embryo 
transfer (IVF/ET) are higher than in the natural cycle (Huang et al,
1986).
Pregnancy cycles are associated with higher P levels in the luteal 
phase (Jones et al, 1984) and many centres support the luteal 
phase on an empirical basis in an attempt to mimic the hormonal 
profiles of conception cycles. Hyperstimulation regimes consisting 
of hMG alone or in combination with CC have been followed by 
luteal phase supplementation with either P (Dlugi et al, 1985), hCG 
(Mahadevan, Leader & Taylor, 1985), or both P and hCG (Forman 
et al, 1988).
Pregnancy rates have shown no significant improvement although 
hCG did prolong the luteal phase (Bayly et al, 1985, Buvat et al, 
1988), which was thought to exert a beneficial effect as poor 
pregnancy rates have been associated with regimes that lead to 
short luteal phases (Quigley, 1985).
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Acceptable pregnancy rates are achieved with no luteal 
supplementation (Russell, Polan & de Cherney, 1986, Van 
Steirteghem et al, 1988). Thus, there is no clear evidence in the 
literature as to the beneficial effect of systematic supplementation 
of the luteal phase in IVF cycles where ovarian stimulation was 
achieved by CC plus hMG or hMG alone.
The combined use of gonadotrophin releasing hormone agonists 
(GnRH-A) and gonadotrophins is an effective and more controlled 
hyperstimulation regime (Rutherford et al, 1988). The endogenous 
hypogonadotrophism during induction of follicular growth with  
exogenous gonadotrophins, eliminates premature luteinisation 
(Fleming et al, 1986). This reversible pituitary suppression may 
influence the adequacy of the luteal phase in establishing a uterine 
environment suitable for nidation.
Some programmes using this form of therapy have supported the 
luteal phase, either with hCG (Neveu et al, 1987, Zorn et al, 1988) 
or with P (Serafini et al, 1988), but without using a control 
population. Similar pregnancy rates have been achieved with the 
use of either hCG or P (Van Steirteghem et al, 1988), again without 
a control population.
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In order to evaluate the effect of support with hCG in the luteal 
phase following hyperstimulation with buserelin and hMG, patients 
in this programme were randomly allocated to receive support or no 
support according to whether the maturational dose of hCG was 
given on an odd or an even date. The pregnancy rate was 
significantly higher in the women who received support with hCG, 
41%  compared to 15% for those who were not supported (Smith 
et al, 1989).
All patients included in this study received luteal phase support in 
the form of hCG, 2500  IU administered on day + 3  and day + 6  
(Day 0 =  maturational dose of hCG).
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CHAPTER 3
IN VITRO FERTILISATION: TECHNIQUES AND PROCEDURES, 
UNIVERSITY OF SOUTHAMPTON AND CHALYBEATE HOSPITAL 
IVF PROGRAMME
3.1 OVARIAN HYPERSTIMULATION
All patients whose follicular fluids were analysed for the purpose of 
these studies received the same stimulation regime.
The LHRH-A, buserelin was administered by nasal spray (200 //g  
three times daily) commencing midway through the luteal phase of 
the pre-treatment cycle. Following menstruation, hMG was given, 
300  I.U. daily, from day 4 and continued until an adequate ovarian 
response was elicited. On average, this required 7 days treatment 
with hMG. If an adequate response had not been achieved after 9 
days treatment, the cycle was abandoned. (Diagram 3 .A).
Final oocyte maturation was induced with hCG (10 ,000  I.U.) and 
oocyte recovery performed 34 hours later.
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3.2  CYCLE MONITORING
All treatment cycles were monitored biochemically and 
ultrasonically.
Biochemical monitoring consisted of measurement of serial serum 
E2 levels. Blood samples were taken on days 4, 7 and daily from 
day 9 onwards. E2 was measured by a commercially available 
radioimmunoassay (Serono Diagnostics, E2 MAIA product number 
12264).
Ultrasound monitoring for the earlier patients in the preliminary 
study was performed by the transabdominal transvesical route, 
using a Phillips SDU 70 0 0 ,3 .5  MHZ transducer.
Later patients in the preliminary study and aJJ patients in the major 
study were monitored with transvaginal U/S, using a Bruel and 
Kjaer, 7 MHZ transducer.
An example of mature follicles as visualised with transvaginal U/S 
is shown in Figure 3 .A.
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3.3 OOCYTE RECOVERY
When the programme first started all oocyte recoveries were 
performed laparoscopically. The abdomen was cleaned with  
0 .015%  chlorhexidine. Under general anaesthesia, a 2L C 0 2 
pneumoperitoneum was induced. Percutaneous aspiration of 
follicles was performed using a 14 gauge double lumen needle 
(Casmed UK, Surrey, UK). Follicles were aspirated using 
mechanical suction controlled by a foot pedal (Craft pump, Rocket, 
UK). If no oocyte was recovered in the aspirate, follicles were 
flushed with heparinised, serum-free culture medium (Earle's Gibco, 
UK) until an oocyte was detected or the flushes became cell-free. 
Oocytes (immediately following detection) were transferred to 
sealed tubes containing 1.5ml culture medium and placed in the 
incubator (Heraeus B5061 EK/C02).
Vaginal ultrasound was introduced during the first year of 
operation. Thereafter all patients underwent oocyte recovery by 
ultrasound guided transvaginal needle aspiration. Light 
premedication with oral lorazepam (1mg) was given 1 hour before 
the procedure. Bolus doses consisting of a combination of 
diazepam (2.5mg) and pethidine (25mg) were given intravenously 
during the procedure, if there was any patient discomfort.
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The vagina was cleaned with 0 .015%  chlorhexidine and then 
washed out with culture medium. Contact gel was applied to the 
vaginal transducer and the transducer encased in a sterile sheath. 
A sterilised needle guide was attached on one side of the 
transducer and the puncturing needle, a 15 gauge, double lumen 
needle (Casmed UK, Surrey, UK) inserted through the guide.
The needle was advanced through the vaginal wall and into the 
ovary. Follicles were aspirated in turn without withdrawal of the 
needle from the ovary, using the same mechanical suction and 
flushing medium as for laparoscopic recoveries.
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3 .4  LABORATORY PROCEDURES
All flushing medium used was Earle's Balanced Salt Solution 
supplied by Gibco UK, 10 x concentrate (Cat. No. 0 4 2 -0 4 0 5 0  H) 
with additions as follows:
Bicarbonate: 4 mmol/L (Sigma, UK)
Pyruvate: 0.1 mmol/L (Sigma, UK)
HEPES: 21 mmol/L (Sigma, UK)
Penicillin: 60 mg/ml 
Streptomicin: 50 mg/ml 
Heparin: 10 ,000  U/L
Osmolality 284  _±_ 2 mOsm/kg.
Flushing medium was made up in batches, filtered using Sterivex 
Filter 0.22X m  filter unit (Millipore, UK) and stored up to a maximum  
of 14 days.
The aspirated fluid from follicles, either initial aspirate or 
subsequent flushes, was poured into sterile Falcon tissue culture 
dishes and examined microscopically.
The recovered oocyte was placed in a 4ml Falcon tube containing 
1.5ml culture medium which had been equilibrated overnight under 
5%  C 0 2 and placed in the incubator.
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The culture medium was supplied by Gibco, UK. Earle's Balanced 
Salt Solution, 10 x concentrate with the following additions:
Bicarbonate: 25 mmol/L (Sigma, UK)
Albumin: 10% (Albuminar 5, Armour Pharmaceutical 
Company Ltd, UK)
Pyruvate: 0.1 mmol/L 
Penicillin: 60 mg/ml 
Streptomicin: 50 mg/ml
Osmolality 284  _+_ 2 mOsm/kg.
At the end of the oocyte recovery, the oocytes were transferred to 
organ culture dishes containing 1ml culture medium and covered 
with 0.8m l light liquid paraffin (Kirby Warrick, UK). These dishes 
had been equilibrated overnight with 5%  C 0 2.
Oocytes were pre-incubated for 6 hours prior to insemination.
After waiting for semen liquefaction to occur, (approximately 10 
minutes in the majority of cases) 3 volumes flushing medium 
containing 10%  albumin were added to the fresh semen sample. 
This was centrifuged at 200xg for 10 minutes. The supernatant 
was discarded and the pellet resuspended in 0.5m l culture medium.
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100/vl of the suspension was layered under 1.5ml culture medium 
in Falcon tubes which had been pre-equilibrated. The spermatozoa 
were allowed to swim-up (approximately 30 minutes) and the top 
tw o thirds removed and used for insemination.
Approximately 1 x 10 5 normal motile sperm were added to each 
oocyte containing dish. The following morning (approximately 18 
hours later) oocytes were examined microscopically for the 
presence of pronuclei.
The cumulus around the oocyte was stripped off using fine 
pipettes, hand-drawn, and the number of pronuclei noted. The 
fertilised oocytes were each then transferred to a fresh culture 
dish, which had been pre-equilibrated.
On the day of embryo-transfer (approximately 42  hours post­
insemination) the fertilised oocytes were examined microscopically 
to establish cleavage and the embryos graded in terms of quality.
GRADE 1
All blastomeres have equal size without anucleate fragments. 
GRADE 2
Not all blastomeres have an equal size and anucleate fragments 
present in at most 20%  of the embryo.
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GRADE 3
Not all blastomeres have an equal size and anucleate fragments are 
present in 20-50%  of the embryo.
GRADE 4
Totally fragmented embryo present.
Immediately prior to the embryo-transfer, embryos selected for the 
transfer were placed in a Falcon tube, containing 0.6m l albumin 
and 0.4m l culture medium. The transfer catheter (Wallace, UK) 
was washed through with culture medium. The embryos were 
drawn up into the catheter in 20 j j \ medium with 10 / j I air bubbles 
at either end. A 1ml syringe was used on the end of the catheter. 
Figure 3.B shows a Wallace Transfer Catheter.
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3.5  EMBRYO TRANSFER
Embryo transfers were performed 42 -46  hours post insemination. 
The patient was placed in the lithotomy position. A bivalve 
speculum, soaked in culture medium, was inserted into the vagina 
and adjusted to obtain the optimal view of the cervix. The cervix 
was cleaned with culture medium. The end of the outer sheath of 
the catheter was placed at the external os and the inner catheter 
passed through the internal os into the uterus. The preset syringe 
was depressed and the embryo(s) transferred.
The catheter was rotated and then withdrawn. The catheter was 
examined under the microscope to ensure all embryos had been 
transferred. Figure 3.C shows typical 2 cell and 4 cell grade 1 
embryos.
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FIGURE 3.C 2 CELL AND 4 CELL GRADE 1 EMBRYOS
3.6  LUTEAL PHASE
All patients undergoing oocyte recovery received hCG luteal phase 
support.
hCG support was given in a dose of 2500  I.U. on day + 3  and on 
day + 6  from the initial hCG (day = 0).
Blood samples were taken on days + 1, + 6 and + 12 for 
estimation of serum E2 and P. P was measured by a commercially 
available radioimmunoassay (Amersham International, Product No. 
1M .3221).
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SECTION 2
DEVELOPMENT
CHAPTER 4
ASSAY DEVELOPMENT AND EVALUATION
4.1 OBJECTIVES
a) To set up a reliable extraction process for PGE2 and PGF2a in
follicular fluid.
b) To develop radio-immuno assays (RIA) for PGF2a and PGE2.
c) To examine the effect of storage of samples at -20°C prior 
to assay.
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4 .2  EXTRACTION MATERIALS AND METHODS
SAMPLE STORAGE
Prior to analysis all samples were stored at -20°C (except for a 
proportion of samples to establish effects of freezing).
METHOD
In the past the most common method for extracting prostaglandins 
has been to extract acidified aqueous solutions with organic 
solvents, such as diethyl ether or ethyl acetate. Prostaglandins can 
be extracted from body fluids, such as plasma or urine, by 
chromatography on columns of XAD-2 resin. (See Chapter 1.4). 
Both methods are time-consuming and require evaporation of 
relatively large amounts of solvent.
The procedure developed by Powell (1982) using octadecylsilyl 
(ODS) silica has been modified for extraction of prostaglandins from 
follicular fluid. ODS silica is a hydrophobic material formed by 
allowing silicic acid to react with octadecyltrichlorosilane.
Prostaglandins are adsorbed by reversed phase chromatography 
followed by elution by normal phase chromatography using a series 
of increasingly polar organic solvents that are not miscible with 
water. Extraction of prostaglandins from aqueous media using 
ODS silica has two main advantages. A relatively clean extract is 
obtained and secondly prostaglandin fractions can be obtained in 
relatively small volumes of volatile organic solvents that can be 
readily evaporated under a stream of nitrogen.
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MATERIALS
Radiolabelled eicosanoids were obtained from Amersham  
International 1 5 ,6 ,8 ,1 1 ,1 2 ,1 4 ,1 5 (n) -3H] PGE2 (Code Number 
TR K .431, Batch 77) [5 ,6 ,8 ,9 ,1 1 ,1 2 ,1 4 ,15(n) -3H] PGF2ff (Code 
Number TRK. 464 , Batch 63). Cartridges of ODS silica were 
obtained from Waters Associates, UK (Sep-pak C18 cartridges).
Prior to extraction, follicular fluid samples were acidified to pH 3-4  
using 0 .5M  citric acid. W ater was added to each 1-2ml sample to 
increase the volume to 5ml. The radiolabelled eicosanoids, 10 
/yCj/ml, were diluted 1 in 400 . 100 fj \ of either eicosanoid, 
approximately 5000  3H dpm, was added to each sample for the 
determination of procedural losses (mass 5pg).
It is necessary to w et the ODS silica with an organic solvent prior 
to use. Ethanol activates the column and the excess ethanol is 
then removed by passing water through the column.
To - ODS Silica
add
10ml Ethanol 
then
10ml W ater
Following the column washing process, the samples were applied 
to ODS silica with these initial and subsequent steps:
Dr EM Smith
Thesis 68 Chapter 4
Fresh or thawed follicular fluid 
samples to be extracted
are
Centrifuged in a Damon IEC centrifuge 
200  x g for 10 mins
then samples are
Acidified with citric acid
before application to
ODS Silica, Sep-pak column
to the column is then applied
10ml 15% Ethanol:85% W ater
followed by
10ml Petroleum Ether (40-60%  fraction) 
and the prostaglandins are eluted with 
10ml Diethyl Ether 
See Figure 4 .A.
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Follicular fluid was applied directly to the column after acidification. 
15% aqueous ethanol elutes materials more polar than 
prostaglandins. W ater remaining in the column is removed by 
passing through petroleum ether. Finally the prostaglandins were 
eluted from the ODS with diethyl ether.
The diethyl ether fraction was evaporated to dryness under 
nitrogen at 30°C and the residue reconstituted in 2ml RIA buffer.
The reagents used to make up the RIA buffer were:
K2HP04 (0.1 M) 
Gelatine (0.1 %) 
EDTA (20 mM)
17.4 g litre -1
1.0 g litre -1 
7.5 g litre -1
1.0 g litre -1
9 .0  g litre -1
Sodium Azide (0.1% ) 
NaCI (0.9% )
The final pH was adjusted with NaOH to pH 7 .5 .
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4.3  DETERMINATION OF PROCEDURAL LOSSES
For every sample:-
Recovery values for the extraction were determined for each of the 
tw o eicosanoids assayed. 0.1m l of a 1 in 4 0 0  dilution of tracer,
10 //Cj/ml was added to the sample before extraction, 
(approximately 5000  dpm). Two count controls consisting of 100  
//I diluted isotope solution in 5ml scintillant (Beckman's Ready Safe 
Solution) were prepared with each extraction. A blank sample (1ml 
RIA buffer made up to 5ml with water) was included with each set 
of 24 follicular fluid samples. For each extracted sample (Section 
4.2) reconstituted in 2 ml RIA buffer, 20%  of the volume (i.e. 
0.4ml) was counted for 3H, with 5ml scintillant in an LKB Minibeta 
Liquid Scintillation Spectrometer (Model 1211). Generally the 
volume of follicular fluid extracted was 1-2ml. The minimum 
volume required was 0.5m l.
In addition:-
A known quantity of PGE2 (5000pg) was added to 10 follicular 
fluids previously extracted and assayed. This was repeated for 
PGF2a. 82%  ( + /- 3% ) and 84%  ( + /- 4% ) respectively of the 
known quantity of prostaglandin added was recovered.
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4 .4  RADIO-IMMUNO ASSAY MATERIALS AND METHODS 
FOR PROSTAGLANDINS
The principal of RIA depends on the competitive binding of radio- 
actively labelled antigen with unlabelled antigen to immunological 
sites of a specific antibody.
The concentration of the antigen in an unknown sample is 
determined by calculating the degree of inhibition of label bound to 
antibody that the antigen causes and comparing it to that caused 
by a known concentration of the same substance used as a 
standard.
MATERIALS
STANDARDS:
PGE2 and PGF2c? were supplied by Sigma, UK.
PGE2 (Product Code No. P5640)
PGF2w (Product Code No. P3023)
Both standards were diluted in RIA buffer to provide a working 
range of 6 .25  pg/ml to 1600 pg/ml. In addition it was possible to 
measure higher concentrations of both prostaglandins by diluting 
samples appropriately iri assay buffer.*
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ANTIBODIES:
Both antibodies were supplied by Dr Keith Hillier, Department of 
Pharmacology, University of Southampton.
PGE2 (Code Number KHE9)
PGF2o (Code Number KHF10)
Antibodies were raised in rabbits using the method of Salmon and 
Karim (1976) after conjugation of eicosanoids to BSA using 1- 
ethyl-3 (3-dimethyl aminopropyl) carbodiimide (Caldwell, Burstein & 
Brock, 1971).
An antiserum titration curve was constructed to choose the 
adequate antiserum dilution, the antiserum being added in 
increasing dilution to a series of tubes all containing the same 
concentration of the tracer. (See Figures 4.B and 4.C)
The antibodies were stored in aliquots at -20°C and diluted on the 
day of the assay in RIA buffer to give 35 -50%  maximum binding of 
labelled eicosanoid per 0.1m l antibody, after overnight incubation. 
This percentage binding is generally that giving the highest 
sensitivity and reproducibility.
The cross reactivity for PGE2 antiserum was 29 .6%  for P G E U  2 .5%  
for PGB2 and 2.1 % for 15-keto - PGEV Cross reactivity for other 
prostaglandins and their metabolites or fatty acids was less than 
1 %.
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The cross reactivity for PGF2<7 antiserum was 6 .7%  for PGD2, 3 .8%  
for PGF1ff and less than 1 % for other prostaglandins and their 
metabolites or fatty acids.
RADIOLABELLED EICOSANOIDS
15,6 ,8 ,11 ,12 ,14 ,1  5(n)-3H] PGE2 (Code Number TRK.431, Batch 77) 
and [5 ,6 ,8 ,9 ,1 1 ,1 2 ,1 4 ,1 5(n)-3H] PGF2a (Code Number TRK.464, 
Batch 63) were both obtained from Amersham International.
Both isotopes were diluted in ethanoLwater, 7:3 to 10 //C;/ml and 
stored under nitrogen at -20  °C. The specific activity was 185 
Cj/mmol to achieve maximum radioactivity with the least mass.
Both isotopes were diluted in RIA buffer on the day of the assay to 
give a 1 in 100 dilution, which was approximately 2 0 ,0 0 0  dpm per 
0.1m l. (This was equivalent to 7 ,000  cpm in the beta counter, i.e. 
efficiency ~ 35% .) (Mass 20pg)
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METHODS
The assay consists of three steps: incubation, separation and 
radioactivity measurement.
Incubation was performed in a series of test tubes (See Table 4 .A).
In summary, a series of tubes, in duplicate, were set up for the 
different controls and the standard curve:- 1 . total radioactivity, 
with no antibody; 2 . measurement of non-specific binding, with the 
antibody replaced by buffer; 3. maximum binding for set antibody 
amount (zero standard), with buffer in place of unlabelled antigen;
4. antibody and the unlabelled antigen in serial dilution for the 
standard curve; 5. sample of known concentration for quality 
control and finally 6 . the unknowns were measured after this series 
of controls and standards.
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TABLE 4 .A
RIA INCUBATION: CONTROLS, STANDARD CURVE AND
UNKNOWNS
TUBES STANDARD ANTIBODY TRACER
FOR: OR UNKNOWN OR BUFFER
Total Count 
Non-Specific 
Binding 
Zero Standard 
Binding 
Standard Curve
Control
Unknowns
Buffer
Buffer
Buffer
Standards in 
Serial Dilution
Known Sample
Unknown Sample
Buffer
Buffer
Antibody
Antibody
Antibody
Antibody
Tracer
Tracer
Tracer
Tracer
Tracer
Tracer
Following overnight incubation at 4°C, separation was performed 
using 0.25m l of dextran-coated charcoal (1 .25%  charcoal, Sigma, 
Product Code Number C 5260 with 0 .25%  dextran, Sigma, Product 
Code Number D 5501, in RIA buffer) added to all tubes except the 
total counts. The tubes were vortexed and left for 10 minutes at 
4°C to allow adsorption by the charcoal of the eicosanoid not 
bound to the antibody.
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The samples were then centrifuged at 500xg for 10 minutes at 4°C 
in a Damon IEC centrifuge and the supernatant decanted into 5ml 
scintillation fluid. These were then counted for 3H as for 
recoveries.
The final assay protocol for the RIA of both prostaglandins was as 
follows:
To: 0.1m l assay buffer alone (for blank and zero standard) or
standards S1-S9 in assay buffer (6.25 to 1600pg/ml) or 
sample to be measured (control and unknowns)
Add
0.1 ml tracer
and
0.1m l 1:125 dilution of anti-PGE2
or
0.1m l 1:2500 dilution of anit-PGF2a 
Incubate overnight at 4°C
Add
0.25m l dextran-coated charcoal 
Centrifuge at 500xg for 10 minutes at 4°C 
Decant supernatant into 5ml scintillation fluid 
Count solution in a beta counter
(Every determination was run in duplicate.)
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4 .5  CALCULATION OF RESULTS
PROCEDURAL LOSSES:
Recovery values were determined for each of the prostaglandins 
assayed.
20%  of the reconstituted sample was counted for 3H with 5ml 
scintillant.
Recoveries were calculated as:
% recovery for = cpmx total volume x 1_x 
each sample volume assayed xTC
TC = total counts added
Recoveries all fell within the range 80 -95% .
Median = 83 .35
RADIOIMMUNOASSAY:
The zero standard binding is the maximum binding between 
antibody and tracer in the absence of unlabelled antigen.
100
1
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This was calculated as:
Bo-Bns x 100  
TC 1 
This was kept within the range 35 -50% .
Non specific binding (NSB) was calculated as: 
NSB(%) =  NSB x 1 0 0  
TC 1
Percentage bound in standards and samples (B/Bo) was calculated 
as:
B/Bo(%) =  B - Bns x 100  
Bo - Bns 1
NSB Non-specific binding
B/Bo Percentage maximum binding
Bo Maximum binding counts
TC Total Counts
Bns Non-specific binding counts
B Sample or standard counts
A standard curve (B/Bo plotted against known prostaglandin 
concentrations) was constructed. The sample prostaglandin 
concentration was calculated from the B/Bo. Results were 
expressed using the equation shown in Diagram 4 .A.
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ASSAY CHARACTERISTICS
Composite standard curves calculated from 45 assays are shown in 
Figures 4.D  and 4.E. The mean and standard deviations are given 
in Tables 4.B and 4.C . The assay detection limit (blank sample 
value minus 2 standard deviations) was less than 100 pg/ml. 50%  
displacement of radiolabelled tracer occurred at 1600 pg/ml for 
PGE2 and 700  pg/ml for PGF2ff. The intra-assay coefficient of 
variations were 4%  and 5%  for PGE2 and PGF2_ respectively and 
the inter-assay coefficient of variations were 1 %  and 8 % for PGE2 
and PGF2w respectively.
TABLE 4.B
BINDING OF STANDARD PGE2
STANDARD B/Bo SD
pg/ml (%)
16000 9.2  0 .8
8000  16.4 0.7
40 0 0  28 .2  0.5
2000  46 .3  0 .8
1000  60 .2  0.8
500 74 .5  0 .6
250  88.1 0 .6
125 92.1 0 .4
62.5  94 .0  0 .7
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TABLE 4.C
BINDING OF STANDARD PGF2„
STANDARD B/Bo SD
pg/ml (%)
16000 4.3 0.8
8000 8.2 0.7
400 0 15.1 0.7
2000 25.6 0.5
1000 41 .2 0.7
500 60.3 0.8
250 75.1 0.8
125 90.2 0.6
62.5 94 .8 0.7
Extracted prostaglandins were serially diluted in assay buffer 
between 1:2 and 1:32. The binding of extract serial dilutions 
(Figures 4.F and 4.G) ran parallel to the standard curves for PGE2 
and PGF2cr
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4 .6  COMPARISON OF EXTRACTION AND NON EXTRACTION 
OF FOLLICULAR FLUID
To establish whether an extraction process is necessary prior to 
radioimmunoassay of prostaglandins 10 samples were equally 
divided. One half of each sample was extracted and assayed and 
compared with the other half assayed without prior extraction on 
mini columns (Sep-pak). (Table 4.D)
TABLE 4.D
UNEXTRACTED: EXTRACTED RATIO FOR PGF2o
SAMPLE NGML-1 NGML-1 %U/E
EXTRACTED UNEXTRACTED X 100
(E) (U)
1 0 .65  < 0 .1  < 1 5 %
2 0 .68  < 0 .1  < 1 5 %
3 1.32 0 .39  29 .5%
4 0 .90  < 0 .1  < 1 1 %
5 1.32 < 0 .1  < 8 %
6 1.32 0.81 61 .3%
7 3 .03  1.17 32%
8 1.09 < 0 .1  < 9 %
9 1.29 < 0 .1  < 8 %
10 1.51 < 0 .1  < 7 %
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Unextracted samples assayed for PGF2cr, showed markedly lower 
concentrations when compared with the same sample assayed after 
extraction. Results ranged between < 7 %  and 61 .3%  of the 
concentrations measured in the extracted samples. (Figure 4.H)
TABLE 4.E
UNEXTRACTED: EXTRACTED RATIO FOR PGE2
SAMPLE NGML-1 NGML-1 %U/E
EXTRACTED UNEXTRACTED X 100
(E) (U)
1 0.71 < 0 .1  < 1 4 %
2 0 .67  0 .39  58%
3 2 .12  0 .86  40 .6%
4 0 .77  < 0 .1  < 1 4 %
5 0 .55  < 0 .1  < 8 %
6 1.16 < 0 .1  < 9 %
7 2 .45  < 0 .1  < 4 %
8 2 .25  < 0 .1  < 5 %
9 1.32 0 .56  42 .4%
10 0 .50  < 0 .1  < 2 0 %
A similar pattern emerged when extracted samples were compared 
with unextracted samples for the PGE2 assay. (Table 4.E)
Smith
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The value in measured prostaglandin concentration for unextracted 
samples ranged between < 4 %  and 58%  of the concentrations 
measured in extracted samples. (Figure 4.1)
CONCLUSIONS
To obtain an accurate estimate of the prostaglandin concentration 
in follicular fluid, it is necessary for all samples to be taken through 
the extraction process described.
Recoveries varied from 80-95%  with the used extraction method 
whereas in some cases as little as < 4 %  of prostaglandin could be 
detected, when no extraction was carried out. A sensitive and 
reproducible method was developed for preparation of follicular 
fluid prior to RIA for prostaglandins.
All results presented hereafter are on extracted follicular fluids.
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4 .7  EFFECT OF FREEZING SAMPLES
Follicular fluids, immediately following the oocyte recovery were 
centrifuged at 200xg for 10 minutes. The supernatant was 
removed and stored at -20°C until extracted and assayed.
To assess the effects of storage at -20°C on the prostaglandin 
concentration, 10 follicular fluids were assayed fresh and also after 
storage (3 months). (Tables 4.F and 4.G)
TABLE 4.F
% CHANGE IN PGF2a CONCENTRATION 
IN FOLLICULAR FLUID ON STORAGE AT -20°C
SAMPLE NGM-1
FRESH
NGML-1
FROZEN
% CHANGE 
FRESH-FROZEN
1 1.8 1.85 + 3%
2 0.15 0.15 0 %
3 4.2 4 .45 +  6 %
4 3.2 3.3 + 3%
5 3.0 3.1 + 3%
6 2.4 2.5 + 4%
7 2.85 3 .0 + 5%
8 3.4 3 .15 -8 %
9 1.4 1.3 -8 %
10 1.8 1.8 0 %
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TABLE 4.G
% CHANGE IN PGE2 CONCENTRATION 
IN FOLLICULAR FLUID ON STORAGE AT -20°C
SAMPLE NGM-1
FRESH
NGML-1
FROZEN
% CHANGE 
FRESH-FROZEN
1 33.5 34 .3 + 2 %
2 20 .6 20 .9 + 1%
3 11.3 12.1 + 7%
4 43.1 40 .6 -6 %
5 65.8 69.8 + 6 %
6 4 .5 4.3 -4%
7 2.5 2.5 0 %
8 11.5 11.0 -4%
9 1.2 1.15 -4%
10 3.3 3 .4 + 3%
The variation in results between assays on fresh samples and 
frozen samples did not exceed 7%  for PGE2 and 8 % for PGF2c,. 
(Figures 4.J and 4.K)
CONCLUSIONS
Study results showed an acceptable rate of variation (within the 
inter-assay variation) to allow frozen storage of samples for up to 3 
months before assay.
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4 .8  RIA FOR OESTRADIOL AND PROGESTERONE 
*
MATERIALS AND METHODS
Oestradiol MAIA Kit, Code Number 12264 supplied by Serono 
Diagnostics. The follicular fluid was assayed without any 
preliminary treatment of the sample. The kit has been designed for 
determination of oestradiol as a direct assay.
The main steps of the assay are:
Sample dilution 1 in 1 ,000 in assay buffer
Addition of second antibody 
coupled to magnetic particles 
20  minutes incubation 
then
Placed on magnetic separator 
then
Decantation of supernatant 
then
Radioactivity counting in gamma counter
The cross reactivity was 1 % for oestrone and less than 1 % for 
other steroid hormones and their metabolites.
then
Incubation of reaction mixture 
3 hours at room temperature
Sample/Standard 
+ tracer 
+ antiserum
then
Dr EM Smith
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The intra-assay variation was 5% . The inter-assay variation was 
8 .5% . The minimal detectable concentration of oestradiol was 45  
pmol/L.
Amerlex -M Progesterone RIA Kit, Code Number IM 3220 /IM  
3 2 2 1 /IM 3 2 2 4  supplied by Amersham. Follicular fluid was assayed 
without any preliminary treatment of the samples. The kit has 
been designed for direct assay.
The main steps of the assay are:
Sample dilution 1 in 1 ,000  in assay buffer 
then
Incubation of reaction mixture Sample/Standard
2 hours at room temperature +  tracer
+ antibody coupled to 
magnetic particles
then
Magnetic Separator 
15 minutes 
then
Discard supernatant/retain pellet 
then
Radioactivity counting in gamma counter
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The cross reactivity was 3 .3%  for 5a pregnan -3, 20-dione and 
less than 3%  for other steroid hormones and their metabolites. The 
intra-assay co-efficient of variation was 5% . The inter-assay co­
efficient of variation was 9% . The mimimum detectable 
concentration of progesterone was 0.25nmol/L.
STATISTICAL ANALYSES
The analysis of data in this thesis has often had to take the form of 
non parametric analysis (often the Mann-Whitney Test for 
comparison) because of skewness of data or non-normally 
distributed data. This has partly resulted from the type of 
populations studied but may also be inherent to some extent in the 
use of radioimmunoassays. The medians and ranges therefore 
defined the data much more appropriately. Where possible, means 
and S.D. and parametric tests have been used for comparison with 
other studies and if these have been the accepted methods of 
analysis.
Statistical analysis has been carried out using the University 
Statgraphics package on an IBM PCAT computer. This package 
has been used for the regression analyses and the best lines of fit 
(regression lines) plotted on graphs associated with this, are plotted 
with the 95%  confidence limits for this line. Logarithmic 
transformations or other models did not fit all data and were 
therefore not adopted.
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4 .9  SUMMARY
It was possible to develop a fast, convenient and moderately 
inexpensive method of extraction for the removal of PGE2 and 
PGF2ff from follicular fluids before assay. These follicular fluids 
could be stored at -20°C for at least 3 months before assay. The 
PGE2 and PGF2ff radioimmunoassays on extracts were reliable and 
reproducible and made the following studies possible. P and E2 
were measured using commercially available assays.
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SECTION 3 
STUDY FINDINGS
91
CHAPTER 5
STUDY 1: PRELIMINARY ANALYSIS OF PROSTAGLANDINS AND  
STEROID HORMONE CONCENTRATIONS IN FOLLICULAR FLUID IN 
RELATION TO OOCYTE RETRIEVAL AND INITIAL OOCYTE 
OUTCOME
5.1 OBJECTIVES
An analysis of the PGE2 and PGF2a concentrations in follicular fluid 
to study the following:
Prostaglandin levels associated with
a) oocyte containing and non-oocyte containing follicles.
b) fertilisation and non-fertilisation of matched oocytes.
c) rates of cleavage of fertilised matched oocytes.
d) grades of embryo.
(The steroid hormones, E2 and P, in follicular fluid were also 
assayed and analysed.)
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5.2  OOCYTE CONTAINING AND NON-OOCYTE 
CONTAINING FOLLICLES
PATIENTS:
Follicular fluids from 18 patients who had both oocyte containing 
and non-oocyte containing follicles at oocyte recovery were 
analysed.
The age range was 23-40  years with a mean of 30 .8  years. Table
5.A shows the indications for IVF.
TABLE 5.A
INDICATIONS FOR IVF
n = 18
Tubal 10
Tubal/Sperm 2
Tubal/Endometriosis 1
Unexplained 2
Mucus Hostility 1
Endometriosis 1
5 patients underwent oocyte recovery using laparoscopy and 13 
patients using transvaginal ultrasound guided oocyte recovery.
Dr EM Smith
Thesis 93 Chapter 5
The numbers of oocyte containing follicles analysed were more 
than double the numbers not yielding oocytes due to the 
preponderance of oocyte containing follicles in all patients (83 
compared to 42).
RESULTS
Table 5.B shows the range and median for the follicular fluid 
prostaglandin levels.
TABLE 5.B
FOLLICULAR FLUID PGE2 AND PGF2a IN OOCYTE 
CONTAINING AND NON-OOCYTE CONTAINING FOLLICLES
MEDIAN RANGE N
ng/ml ng/ml
Oocyte Containing Follicles 3 .40  0 .4 -86 .3  83
PGE2
Non-oocyte Containing Follicles 4.21 (ns) 0 .1 8 -8 0 .3  42
PGE2
Oocyte Containing Follicles 1.35 0 .1 -22 .5  83
p g f 2o
Non-oocyte Containing Follicles 1.45 (ns) 0 .2 -1 6 .5  4 2
PGF2w
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
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However, PGE2 levels, showed a significant correlation with PGF2a 
levels in both oocyte containing (p < 0 .001 , r =  0 .87) and non 
oocyte containing (p < 0 .0 0 1 , r = 0.53) follicles.
No significant difference in the PGE2/PGF2ct ratio was shown. (See 
Table 5.C.)
TABLE 5.C
FOLLICULAR FLUID PGE2:PGF2a RATIO IN OOCYTE 
CONTAINING AND NON-OOCYTE CONTAINING FOLLICLES
MEDIAN RANGE
Oocyte Containing Follicles 3 .0 0  0 .2 4 -1 6 .4
Non-oocyte Containing Follicles 2 .89  (ns) 0 .1 8 -1 5 .4 8
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
When these results were analysed on an individual basis wide 
variations were seen both within the non-oocyte containing and the 
oocyte containing follicles.
Table 5.D lists the results for one individual who had transvaginal 
ultrasound guided egg recovery.
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TABLE 5.D
FOLLICULAR FLUID PGE2/ PGF2w AND THE PGE2:PGF2a RATIO IN 
ONE SUBJECT
ORDER OF 
ASPIRATION
pge2
ng/ml
PGF2ff
ng/ml
PGE2:PGF
Non-oocyte 1 9.1 1.5 6 .07
Containing 4 1.9 1.4 1.36
Follicles 8 0.7 0.2 3.5
10 0.9 1.05 0.86
12 1.9 1.0 1.9
Oocyte 2 13.8 0.9 15.3
Containing 3 0.4 1.35 0.3
Follicles 5 6.2 1.35 4 .5 9
6 4.5 10.35 0 .43
7 0.7 2 .4 0 .29
9 2.7 0.8 3 .38
13 8.2 0.5 16.4
14 8.4 1.05 8.0
The concentrations of PGE2 and PGF2c? were not related to order of 
aspiration and therefore not influenced by the aspiration procedure. 
There was no statistical difference for the PGE2 and PGF2a 
concentrations or the PGE2:PGF2ct ratio in one individual when non 
oocyte containing follicles were compared with oocyte containing 
follicles.
Table 5.E shows the follicular fluid E2 and P levels for oocyte 
containing and non-oocyte containing follicles. Once again no 
statistical differences were shown.
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TABLE 5.E
FOLLICULAR FLUID E2 AND P LEVELS AND E2:P RATIO IN 
OOCYTE CONTAINING AND NON-OOCYTE CONTAINING  
FOLLICLES
MEDIAN RANGE N
Oocyte Containing Follicles
E2 (nmol/L) 680  11-3400
P (//mol/L) 15 1.5-55
E2:P ( x  10'3) 51 13-767
Non-oocyte Containing Follicles 
E2 (nmol/L) 680 (ns) 68 -2300
P (//mol/L) 13 (ns) 1.5-42
E2:P ( x  10'3) 49 .5  (ns) 10-110
85
31
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
Follicular fluid E2 concentration correlated significantly with the P 
concentration for both non-oocyte containing (p<  0 .0 0 1 , r = 0 .71) 
and oocyte containing (p < 0 .001 , r = 0 .46) follicles. (Figures 5 .A 
and 5.B.)
No significant correlation was shown between follicular fluid PGE2 
levels and either E2 or P levels. Also no significant correlation was 
shown between follicular fluid PGF2ff and E2 or P.
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5.3 FERTILISATION AND NON-FERTILISATION OF THE 
MATCHED OOCYTE
PATIENTS
The same patient group as in 5 .2  was included in this study. Forty 
three follicular fluids from which the matched oocyte did not 
fertilise were compared with 82 follicular fluids from which the 
matched oocyte did fertilise.
RESULTS
Concentrations of PGE2 and PGF2ff are shown in Table 5.F. 
TABLE 5.F
FOLLICULAR FLUID PGE2 AND PGF2a FROM FERTILISED 
AND UNFERTILISED OOCYTES
MEDIAN RANGE N
ng/ml ng/ml
Fertilised Oocyte PGE2 3 .25  0 .5 -327  82
Unfertilised Oocyte PGE2 4 .3 4  (ns) 0 .4 -337  43
Fertilised Oocyte PGF2w 1.33 0 .1 -3 1 .5  82
Unfertilised Oocyte PGF2w 1 .40 (ns) 0 .2 -5 2 .5  43
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
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There was no significant difference whether or not fertilisation 
occurred in the matched oocyte. The PGE2:PGF2w ratio was also 
not significantly different. (Table 5.G.)
TABLE 5.G
FOLLICULAR FLUID PGE2:PGF2a RATIO FROM FERTILISED AND  
UNFERTILISED OOCYTES
MEDIAN RANGE
Fertilised Oocytes 2 .53  0 .6 7 -1 6 .4
Unfertilised Oocytes 3 .33  (ns) 0 .2 1 -1 0 .0
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
PGE2 levels correlated significantly with PGF2cr levels for both 
fertilised (p < 0 .0 0 1 , r = 0 .95) and unfertilised (p c O .0 0 1 , r =  0 .96) 
oocytes. (Figures 5.C and 5.D)
The follicular fluid E2 and P levels were not significantly different.
(Table 5.H.) The ratio of E2 to P also did not differ significantly.
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TABLE 5.H
FOLLICULAR FLUID E2 AND P LEVELS AND E2:P RATIO FROM 
FERTILISED AND UNFERTILISED OOCYTES
MEDIAN RANGE N
Fertilised Oocytes 
E2 (nmol/L)
P (/vmol/L)
E2:P ( x  1 0 - 3 ) 
Unfertilised Oocytes 
E2 (nmol/L)
P (//mol/L)
E2:P (x10‘3)
82
730
19
49
800 (ns) 
20  (ns) 
35 (ns)
82 -34 00
1-55 
10-767
52 -34 00
2-43  
15-174
43
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
There was a significant correlation between follicular fluid E2 and P 
levels in both the fertilised group (p < 0 .001 , r = 0 .53) and the 
unfertilised group (p < 0 .0 5 , r = 0 .39).
As seen in the previous analysis no significant correlations were 
shown between either PGE2 or PGF2o and either E2 or P in follicular 
fluid.
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5.4  RATES OF CLEAVAGE OF THE FERTILISED MATCHED 
OOCYTE
PATIENTS
The same patient group as in 5 .2  was used to compare follicular 
fluids from oocytes resulting in 2 cell embryos and oocytes 
resulting in 4 cell embryos in the same time period.
RESULTS
No significant difference was seen for either PGE2 or PGF2ff levels in 
follicular fluid for either 2 cell or 4 cell embryos. (Table 5.1.)
TABLE 5.1
FOLLICULAR FLUID PGE2 AND PGF2cr ASSOCIATED W ITH 2 
CELL EMBRYOS AND 4 CELL EMBRYOS
MEDIAN RANGE N
ng/ml ng/ml
2 cell embyro PGE2 3 .2  0 .5 -327  27
4 cell embryo PGE2 3 .4  (ns) 0 .5 -6 0 .9  40
2 cell embryo PGF2a 1.5 0 .1 5 -3 1 .5
4 cell embryo PGF2t/ 1.15 (ns) 0 .1 -10 .5
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney).
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The only difference observed was some inidividually high results for 
both prostaglandins with 2 cell embryos. The PGE2:PGF2a ratio was 
not significantly different. (Table 5.J).
TABLE 5.J
FOLLICULAR FLUID PGE2:PGF2a RATIO FROM 2 CELL AND 4  
CELL EMBRYOS
MEDIAN RANGE N
2 cell embyros 2.51 0 .6 7 -1 6 .4  27
4 cell embryos 2 .46  (ns) 0 .6 7 -1 4 .4  40
ns = not significant by Non-parametric analysis (Mann-Whitney).
A significant correlation was shown between PGE2 and PGF2a levels 
in follicular fluid from both 2 cell embryos (p < 0 .0 0 1 , r = 0 .96) and 
4 cell embryos (p cO .001 , r = 0 .85).
E2 and P concentrations did not differ significantly whether the 
embryo was at the 2 or the 4 cell stage at the time of transfer. 
(Table 5.K.)
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TABLE 5.K
FOLLICULAR FLUID E2 AND P LEVELS AND THE E2:P RATIO 
ASSOCIATED W ITH 2 CELL EMBRYOS AND 4 CELL EMBRYOS
MEDIAN RANGE N
2  Cell Embyros 2 7
E2 (nmol/L) 7 0 5  1 3 0 - 3 4 0 0
P (/ymol/L) 2 3  2 - 4 7
E2:P ( x  1 0 " 3 ) 3 9 . 5  1 0 - 2 2 8
4 Cell Embyros 40
E2 (nmol/L) 680(ns) 105 -3400
P Ot/mol/L) 18 (ns) 1-55
E2:P ( x  10'3) 50 (ns) 13-220
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
The follicular fluid E2 levels correlated highly significantly with the P 
level in both the 2 cell embryos (p < 0 .0 0 1 ; r = 0 .41) and the 4 cell 
embryos (p < 0 .0 0 1 , r = 0 .53).
There were no significant correlations shown between either PGE2 
or PGF2„ and either E2 or P levels.
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5.5 GRADE OF EMBRYO FROM THE FERTILISED 
MATCHED OOCYTE
PATIENTS
Follicular fluids from the same patient group as in 5 .2  were 
analysed. 42  follicular fluids from oocytes that fertilised and 
resultant embryos graded as 1 and 2 were compared with 22  fluids 
from oocytes that resulted in 3 and 4 embryos.
RESULTS
Table 5.L shows the median and range of PGE2 and PGF2cj. There 
was no significant difference between different grades of embryo 
quality.
TABLE 5.L
FOLLICULAR FLUID PGE2 AND PGF2a FROM GRADE 1 AND 
2 AND GRADE 3 AND 4 EMBRYOS
MEDIAN RANGE N
ng/ml ng/ml
Grade 1 & 2 PGE2 4 .7  0 .7 -9 4 .4  41
Grade 3 & 4 PGE2 2.8 (ns) 0 .5 -8 6 .3  22
Grade 1 & 2 PGF2a 1.35 0 .1 -1 2 .0  41
Grade 3 & 4 PGF2w 1.4 (ns) 0 .1 -2 7 .0  22
ns =  not significant when compared by Non-parametric analysis 
(Mann-Whitney).
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TABLE 5.M
FOLLICULAR FLUID PGE2:PGF2ff RATIO FROM GRADE 1 AND 2 
AND GRADE 3 AND 4 EMBRYOS
MEDIAN RANGE N
Grade 1 & 2 3 .09  0 .9 3 -1 6 .4  41
Grade 3 & 4 3 .43  (ns) 0 .6 7 -8 .5 7  22
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney).
As with the other outcomes analysed the PGE2:PGF2ct ratio was also not 
significantly different.
Once again PGE2 correlated significantly with PGF2a for both 
embryo categories. (Grade 1 & 2, p < 0 .0 0 1 , r = 0 .85) (Grade 3 &
4, p < 0 .005 , r = 0 .62)
Table 5.N shows the median and range for E2 and P in these 
embryos. No significant differences were shown.
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TABLE 5.N
FOLLICULAR FLUID E2 AND P LEVELS AND THE E2:P RATIO 
ASSOCIATED W ITH GRADE 1 AND 2 AND GRADE 3 AND 4  
EMBRYOS
MEDIAN RANGE N
Grade 1 and 2 41
E2 (nmol/L) 510  105 -3400
P (//mol/L) 13 1-55
E2:P ( x  10'3) 31 10-132
Grade 3 and 4 22
E2 (nmol/L) 740  (ns) 170 -2200
POc/mol/L) 15 (ns) 1-39
E2:P ( x  10'3) 50 (ns) 11-112
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney).
The follicular fluid E2 levels correlated significantly with P levels for 
both Grade 1 and 2 embryos (p < 0 .001 , r = 0 .42) and Grade 3 and 
4 embryos (p < 0 .0 1 , r = 0 .63).
No correlation was seen between either follicular fluid PGE2 or 
PGF2o and either E2 or P.
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5.6 SUMMARY
PGE2/ PGF2a, E2 and P were measured in follicular fluids obtained at 
oocyte recovery of patients undergoing IVF for various indications. 
Considerable variation for prostaglandins and steroids was found in 
the majority of individuals. Comparisons were made in regard to 
the presence or absence of an oocyte, fertilisation, cleavage and 
grade of embryos. No significant differences were shown for any 
comparison between groups for this non select group of patients 
and differing IVF practices.
There were no correlations between the prostaglandins and the 
steroid hormones. Nevertheless there were significant correlations 
in all groups for PGE2 vs PGF2a and E2 vs P.
These studies showed that no obvious differences in prostaglandin 
levels could be shown with such diverse groups. Therefore if any 
important relationships existed further studies were necessary with 
more discrete groups and with IVF success in terms of pregnancies.
Study 2 was therefore set up to investigate more select groups.
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CHAPTER 6
STUDY 2: A MORE EXTENSIVE ANALYSIS OF PROSTAGLANDINS 
IN FOLLICULAR FLUID IN RELATION TO FERTILISATION OF THE 
MATCHED OOCYTE AND PREGNANCY OUTCOME
PATIENT RECRUITMENT, OOCYTE FERTILISATION AND 
PREGNANCY
6.1 INTRODUCTION
Study 1 failed to establish a significant relationship between the 
levels of the measured follicular fluid components and the initial 
outcome of the matched oocyte. But there were a number of 
variables in that study that may have affected the results.
Refinements were made in this continuing study to attempt to 
exclude any factor influencing the quality of oocytes or 
spermatozoa. The patient group selected for this study had a 
purely mechanical indication for IVF. Those with any evidence of 
endometriosis, present or past, were excluded. Patients with so far 
unexplained infertility were also excluded as it has been our 
experience that previously unsuspected male or female problems 
have come to light in a significant percentage of those patients 
whilst undergoing IVF.
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The method of ultrasound monitoring and the technique used for 
oocyte recovery were not standardised in the previous study. Five 
out of the 18 patients underwent laparoscopic oocyte recovery 
using general anaesthesia. The 100%  C 0 2 pneumoperitoneum 
required for laparoscopy may have adverse effects on oocyte 
quality because rapid uptake of C 0 2 may decrease follicular fluid 
pH. General anaesthesia may also exert adverse effects. However, 
comparisons of the two methods of IVF in the preliminary study 
were not able to yield significant differences between TVU  
methods and laparoscopic methods. The PGE2:PGF2a ratio for 
laparoscopy follicular fluids ranged from 0 .2 4  to 15.48 and TVU  
from 0.1 8 to 16.4.
Boyers et al (1987), in a paired analysis of in vitro fertilisation and 
cleavage rates of first versus last recovered oocytes, showed a 
significantly decreased fertilisation rate in last recovered oocytes 
when the time between first and last oocytes exceeded 5 minutes. 
Separation of C 0 2 and general anaesthetic effects was not possible 
as both were used concurrently. Cleavage rates were similar in 
both first and last recovered oocytes.
In contrast, Hayes et al (1987) showed no differences in 
fertilisation rates between early and late recovered oocytes but 
cleavage rates were decreased.
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All patients included in this study 2, underwent oocyte recovery by 
ultrasound guided transvaginal aspiration. Any possible influence 
of a C 0 2 pneumoperitoneum and the effects of general anaesthesia 
were removed from this study.
The IVF programme had by the second year of operation achieved 
acceptable pregnancy rates and therefore this was now a further 
factor to be studied in relation to follicular fluid prostaglandin and 
steroid hormone levels.
Selection criteria for Study 2 were therefore much more refined and 
this would be reflected in results found.
)r EM Smith
'hesis 110 Chapter 6
6.2 OBJECTIVES OF STUDY 2
To study the relationship between PGE2 and PGF2a, E2 and P 
concentrations in follicular fluid and the outcome of the matched 
oocyte in the following terms:
a) Fertilisation or non-fertilisation
b) Establishment or non-establishment of pregnancy
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6.3 PATIENT CRITERIA
Patients included in this study had a purely mechanical problem 
causing their infertility. Only patients with tubal blockage or mucus
hostility were included. Patients with endometriosis, unexplained
infertility and male factor problems were excluded. (Table 6 .A).
TABLE 6 .A
NUMBER OF PATIENTS, CYCLES AND INDICATIONS 
FOR IVF
No Of No Of
Patients Cycles
Tubal Blockage- 40  47
Mucus Hostility 5 5
33 patients were undergoing their 1st IVF attempt, 10 their 2nd 
attempt, 1 patient her 3rd attempt and 1 patient her 4th attempt.
The age of patients fell within the range, 24 -40  years, mean 33  
years.
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6.4  OVARIAN HYPERSTIMULATION
All patients in the study received the same drugs, buserelin and 
hMG. Buserelin was administered as previously stated in Chapter 
3. HMG was administered, commencing on day 4 of the treatment 
cycle, in a daily dosage of 4 ampoules until an adequate response 
was achieved. Only 2 patients received a higher daily dose of 
hMG, i.e. 6 ampoules because of previous failure to respond 
adequately on the lower dose. Both conceived on the higher 
dosage.
The dosage of hMG required are shown in Table 6 .B.
TABLE 6 .B
NUMBER OF CYCLES FOR A PARTICULAR TOTAL
hMG DOSAGE
AMPS hMG NO. OF CYCLES
24 6
28 31
32 9
36 4
42
48
* 6 amps daily
1 amp hMG = 75 IU FSH, 75 IU LH
The mean and mode for the number of ampoules of hMG
required was 28.
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6.5 CYCLE MONITORING
Patients were monitored by biophysical and biochemical methods. 
All patients had, on vaginal ultrasound, at least 2 follicles 
measuring more than 17mm for the oocyte maturation dose of hCG 
to be given.
The serum oestradiol levels on the same day were in the range 
1800 - 2 5 ,0 0 0  pmol/L, median 4 2 5 0  pmol/L. Adequate E2 levels 
were considered to be around 4 00  pmol/L per mature follicle.
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6.6 OOCYTE RECOVERY
All recoveries were performed using transvaginal ultrasound guided 
needle aspiration as detailed in Chapter 3.
Table 6 .C shows the average numbers of follicles aspirated per 
patient, the average number of oocytes recovered per patient and 
the oocyte yield for the number of follicles aspirated.
TABLE 6 .C
NUMBERS OF FOLLICLES ASPIRATED, NUMBERS OF 
OOCYTES RECOVERED AND OOCYTE YIELD
MEAN RANGE
Follicles Aspirated 12.6 4-26
Oocytes 11.04 3-26
Oocyte Yield 89 .6%
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6.7 EMBRYO TRANSFER
All embryo transfers were performed using a 1ml syringe and a 
Wallace catheter.
The mean fertilisation rate was 77 .7% .
Figure 6 .A shows the percentage of patients receiving 2, 3 or 4  
embryos per transfer.
All patients received luteal phase support as hCG, 250 0  I.U. on 
days + 3  and + 6  (oocyte maturational dose of hCG given on day 
0).
Dr EM Smith
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6.8 PREGNANCIES
22 of the 52 cycles analysed resulted in pregnancy. Pregnancy 
was diagnosed by a positive fetal heart beat on ultrasound. 
Biochemical pregnancies were excluded.
Table 6 .D shows the indications for IVF in these patients.
TABLE 6 .D
INDICATION FOR IVF IN THOSE PATIENTS ESTABLISHING 
A PREGNANCY
N = 22
Tubal 17
Mucus 5
The ages ranged between 26 and 40 years with a mean of 32 .5  
years.
All patients had either 3 or 4 embryos transferred. Table 6 .E 
shows the implantation rate per embryo transferred.
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TABLE 6.E
IMPLANTATION RATE PER EMBRYO TRANSFERRED
NO OF NO IMPLANTATION
EMBRYOS IMPLANTING RATE
Overall
3 Embryos
4 Embryos 48
78
30
31
20
11
39 .7%
36 .7%
41 .7%
One multiple pregnancy, twins, occurred in the 10 patients who 
had 3 embryos transferred and 7 multiple pregnancies occurred in 
the 12 patients who had 4 embryos transferred, 6 sets of twins 
and 1 set of triplets.
All pregnancies resulted from the transfer of at least one grade 1 
embryo. There were no significant differences in the numbers of 
transferred grade 1 embryos between the 'pregnancy' and the 'no 
pregnancy' group. (Figure 6 .B) Table 6 .F shows the outcome of 
the pregnancies.
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TABLE 6.F
THE OUTCOME OF THE PREGNANCIES
OUTCOME OF PREGNANCIES
Delivered 16
Aborted < 1 2 /5 2 1
Aborted > 1 2 /5 2 2
Ectopic 2
Intra-uterine death 1
2 of the three abortions were twin pregnancies as was the intra­
uterine death which occurred at 28 weeks. There were 3 neonatal 
deaths, one occurring in a twin pregnancy and due to prematurity, 
and the other tw o due to fetal abnormality. One of the triplets had 
oesophageal atresia with a tracheo-oesophageal fistula and one 
singleton pregnancy had Potter's syndrome.
The 2 ectopics were diagnosed at 7 weeks and 8 weeks. Both had 
positive fetal heart beats at the time of diagnosis.
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6.9 SUMMARY
A purer patient group with only mechanical indications for IVF were 
selected for Study 2. IVF practices were standardised for the 
entire group. The oocyte recovery rate for follicles aspirated was 
around 90% . Only 2%  of patients had less than 3 embryos 
transferred and all pregnancies occurred when 3 or 4 embryos were 
transferred. There was no significant difference in the implantation 
rate for 3 or 4 embryos. However a significantly higher number of 
multiple pregnancies occurred when 4 embryos were transferred. 
There was a 27%  loss rate among the IVF pregnancies.
Dr EM Smith
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CHAPTER 7
Dr EM
Thesis
CYCLE MONITORING OF SERUM OESTRADIOL AND 
PROGESTERONE LEVELS FOR STUDY 2.
7.1 FOLLICULAR PHASE
Serum E2 was measured on the day that the maturational dose of 
hCG was given (day = 0). Results are expressed for all the 
patients included in the study and then subdivided dependent on 
whether or not pregnancy resulted (Table 7 .A).
TABLE 7 .A
SERUM E2 ON DAY 0
All patients 
Not Pregnant 
Pregnant
MEDIAN RANGE N
pmol/L pmol/L
3 95 0  180 0 -2 2 ,5 0 0  52
40 0 0  180 0 -2 2 ,5 0 0  30
3 35 0  (ns) 2 0 5 0 -6 ,7 5 0  22
ns =  not significant when compared by Non-parametric analysis (Mann- 
Whitney).
The range of E2 for the patients who subsequently established a 
pregnancy is narrower than for those who did not but this did not reach 
significance. No patient with an E2 greater than 6750  pmol/L on day 0 
became pregnant.
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7 .2  LUTEAL PHASE
Blood samples were taken on days 1, 6 and 12 (Day of hCG =  Day 
0) in the luteal phase and assayed for E2 and P. Table 7.B shows 
the median and range for E2/ P and the E2:P ratio on day 1.
TABLE 7.B
SERUM E2/ P AND E2:P RATIO ON LUTEAL DAY 1
MEDIAN RANGE N
ALL PATIENTS 52
E2 pmol/L 3 7 0 0 8 5 0 - 2 4 , 5 0 0
P nmol/L 1 6 6 - 6 0
E2:P ( x  1 0 - 3 ) 2 5 5 2 5 - 5 9 6
NO PREGNANCY 30
E2 pmol/L 3 9 0 0 8 7 5 - 2 4 , 5 0 0
P nmol/L 1 6 6 - 6 0
E2:P ( x  1 0 - 3 ) 2 3 3 2 5 - 5 9 6
PREGNANCY 22
E2 pmol/L 3 6 2 4  (ns) 1 8 5 0 - 9 , 2 5 0
P nmol/L 1 5  (ns) 6 - 3 0
E2:P ( x  1 0  3 ) 2 7 1  (ns) 8 8 - 4 3 0
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney) to the 'no pregnancy' group.
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The day 1 serum levels of both E2 and P and also the ratio of E2:P 
were not significantly different whether or not pregnancy was 
subsequently established.
However there was a highly significant correlation between the 
serum E2 concentration and the serum P concentration on day 1 for 
all patients (p < 0 .001). (Figure 7 .A)
This correlation was also shown when the patients were subdivided 
in the respective non-pregnant and pregnant groups (p < 0 .0 0 1 ) 
(Table 7.C).
TABLE 7.C
CORRELATION BETWEEN SERUM E2 AND P ON LUTEAL
DAY 1
r N
All patients < 0.001 0 .80 52
No pregnancy < 0.001 0 .78 30
Pregnancy < 0.001 0 .89 22
The total E2 on day 1 is a reflection of the number of follicles that 
have been stimulated and therefore the number of oocytes 
recovered.
Table 7.D shows the results of oocyte recoveries and the 
fertilisation rate.
)r EM Smith
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TABLE 7.D
NUMBERS OF FOLLICLES ASPIRATED AND OOCYTES 
RECOVERED AND THE FERTILISATION RATE.
RANGE N 
52
4-24
3-26
36 -100%
30
4 -24  
3-26
46 -10 0%
22
5-22  
5-21
36 -100%
ns =  not significant when compared by Non-parametric analysis 
(Mann-Whitney)
There were no differences between the no pregnancy group and 
the pregnancy group in terms of numbers of follicles aspirated, 
oocytes recovered and the fertilisation rate.
MEAN
ALL PATIENTS
No. Follicles aspirated 12.60
No. Oocytes recovered 11.04
Fertilisation rate 77 .7%
NO PREGNANCY
No. Follicles aspirated 13.77
No. Oocytes recovered 12.03
Fertilisation rate 79 .7%
PREGNANCY
No. Follicles aspirated 11 .00  (ns)
No. Oocytes recovered 10.36 (ns)
Fertilisation rate 76 .0%
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The numbers of follicles aspirated and the numbers of oocytes 
recovered correlated highly significantly in both groups (p < 0 .0 0 1 ) 
(r = 0 .93  in the 'no pregnancy' group, r = 0 .85  in the 'pregnancy' 
group). (Figure 7.B)
Significant correlations were shown between the serum E2 
concentration on day 1 and both the numbers of follicles aspirated 
and the numbers of oocytes recovered (Table 7.E). The mean day 
1 serum E2 per oocyte recovered was 386  pmol/L with a range of 
169 - 1042 pmol/L.
TABLE 7.E
CORRELATION BETWEEN SERUM E2 ON LUTEAL DAY 1 
AND NUMBERS OF FOLLICLES ASPIRATED AND OOCYTES 
RECOVERED
N
ALL PATIENTS 52
Follicles aspirated 
Oocytes recovered 
NO PREGNANCY 
Follicles aspirated 
Oocytes recovered 
PREGNANCY
< 0 .0 0 5  0 .52
< 0.001  0.61
< 0 .0 0 1  0 .53
< 0 .0 0 1  0 .63
30
22
Follicles aspirated 
Oocytes recovered
< 0 .0 0 5  0 .62
< 0 .0 5 0.51
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Figure 7.C shows the correlation for all patients taken collectively. 
The serum P on day 1 also correlated significantly with the 
numbers of follicles aspirated and oocytes recovered (Table 7.F).
TABLE 7.F
CORRELATION BETWEEN SERUM P ON LUTEAL DAY 1 
AND NUMBERS OF FOLLICLES ASPIRATED AND OOCYTES 
RECOVERED
ALL PATIENTS 
Follicles aspirated 
Oocytes recovered 
NO PREGNANCY 
Follicles aspirated 
Oocytes recovered 
PREGNANCY 
Follicles aspirated 
Oocytes recovered
£ r N
52
< 0 .0 0 1  0 .63
< 0.001 0.68
30
< 0 .0 0 1  0 .64
< 0 .0 0 1  0.73
22
< 0 .0 0 5  0 .64
< 0 .0 5  0 .47
The next tw o tables (7.G and 7.H) show the median and range for 
E2, P and the E2:P ratio on day 6 and day 12 of the luteal phase.
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TABLE 7.G
SERUM E2/ P AND E2:P RATIO ON LUTEAL DAY 6
MEDIAN RANGE N
ALL PATIENTS 52
E2 pmol/L 3375 1 2 5 0 -16 ,000
P nmol/L 180 75 -2 ,3 6 0
E2:P (x 10'3) 19.5 6-56
NO PREGNANCY 30
E2 pmol/L 3375 1 3 5 0 -16 ,000
P nmol/L 177.5 93 -2360
E2:P (x 10'3) 21.5 8-56
PREGNANCY 22
E2 pmol/L 3375 (ns) 1250 -7 ,5 00
P nmol/L 180 (ns) 75 -440
E2:P (x 10'3) 18 (ns) 6-50
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney) or analysis of variance.
Extreme results in the 'no-pregnancy' group are caused by isolated 
cases. For those patients who established a pregnancy the range 
for both E2 and P was much narrower although this was not 
reflected in the E2:P ratio. Pregnancy did not result if the E2 
exceeded 750 0  pmol/L or the P exceeded 4 40  nmol/L on day 6 .
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However, there was no significant difference between the 'non- 
pregnant' group and the 'pregnant group' in either the E2 or the P 
levels on luteal day 6 .
TABLE 7.H
SERUM E2/ P AND E2:P RATIO ON LUTEAL DAY 12
MEDIAN RANGE N
ALL PATIENTS 52
E2 pmol/L 1 0 0 0 8 6 - 1 5 , 0 0 0
P nmol/L 2 6 5 - 3 8 5
E2:P ( x  1 0 ' 3 ) 3 4 1 5 - 1 0 8
NO PREGNANCY 30
E2 pmol/L 1 0 0 0 8 6 - 1 5 , 0 0 0
P nmol/L 1 1 5 - 3 8 5
E2:P ( x  1 0 * 3 ) 3 9 1 5 - 1 0 8
PREGNANCY 22
E2 pmol/L 2 3 0 0  (ns) 4 7 0 - 5 , 0 0 0
P nmol/L 1 0 5  * * * 1 2 - 2 5 5
E2:P ( x  1 0 ' 3 ) 22  (ns) 1 6 - 4 1
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney) or analysis of variance.
* * *  p < 0.001
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Again a much narrower range for E2 and P for the pregnancy 
groups is found on day 12. This was also shown for the E2:P ratio.
No statistical difference was shown for the E2 levels on luteal day 
12 between the 'non-pregnant' and the 'pregnant' group but a 
highly significant difference was shown for P levels (p < 0 .001 ). 
However the E2:P ratio did not differ significantly.
There was a significant correlation between the E2 levels on luteal 
day 6 and the P levels (p < 0 .0 5 ) and this correlation was even 
more significant on day 12 (p < 0 .0 0 1 ) for all patients.
On luteal day 6 , this correlation was not shown when the patients 
were analysed in terms of pregnancy or no pregnancy.
However, on luteal day 12, E2 levels correlated significantly with P 
levels in both the 'non-pregnant' group (p < 0 .0 0 1 ) and the 
'pregnant' group (P < 0 .0 0 5 ).
E2 levels on luteal day 6 showed a significant correlation with the 
E2:P ratio for all patients (p < 0 .005), the 'non-pregnant' group 
(p < 0 .0 5 ) and the 'pregnant' group (p < 0 .0 5 ).
Only in the 'pregnant' group was a significant correlation shown 
between P levels on luteal day 6 and the E2:P ratio (p < 0 .0 5 ). 
Neither the E2 nor the P levels correlated significantly with the E2:P 
ratio on luteal day 12 .
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7.3 SUMMARY
Serum oestradiol and progesterone levels were analysed in this 
select group of patients and correlations and statistical differences 
among the various groups were calculated. The importance of so 
many combinations was to deduce overall trends and important 
relationships rather than just throw up one statistical result which 
could have occurred by chance (rather than be of any biological 
significance).
It was shown that statistical differences were not found before 
oocyte retrieval even though much narrower ranges for E2 and P 
were obtained within the 'pregnancy' group as one would have 
hoped. The wider ranges of the 'no pregnancy' group were caused 
by some isolated cases which did not affect overall significances.
A lack of difference was also found when the number of oocytes 
recovered in the 'pregnancy group' was compared with the 'no 
pregnancy' group. However significant correlations were obtained 
between E2 and P concentrations and oocytes recovered.
Differences between the 'no pregnancy' group and the 'pregnancy' 
group did not appear until late on in the luteal phase. A highly 
significant elevated progesterone result was found on day 12 in the 
luteal phase of the 'pregnancy' group.
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CHAPTER 8
FOLLICULAR FLUID ANALYSIS OF PROSTAGLANDINS, 
OESTRADIOL AND PROGESTERONE LEVELS FOR STUDY 2.
INTRODUCTION
Follicular fluids were collected from this select group of patients for 
study 2 (See Section 6.3). The method of aspiration was as 
described in Section 3 .3 . PGE2 and PGF2a were measured in 
follicular fluids along with oestradiol and progesterone.
8.1 FOLLICULAR FLUID GROUPING
Follicular fluids were assigned to one of 4 groups dependent upon 
the outcome of the matched oocyte.
GROUP 1
Follicular fluids from oocytes that did not subsequently fertilise. 
GROUP 2
Follicular fluids from oocytes that did fertilise, but were not 
transferred.
GROUP 3
Follicular fluids from oocytes that did fertilise, were transferred but 
pregnancy did not result.
GROUP 4
Follicular fluids from oocytes that did fertilise, were transferred and 
pregnancy did result.
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Results were analysed in terms of the outcome of the matched 
oocyte. Table 8 .A shows the number of follicular fluids in each of 
the 4 groups.
TABLE 8 .A
FOLLICULAR FLUID GROUP CATEGORY ACCORDING TO 
THE OUTCOME OF THE MATCHED OOCYTE.
NUMBER
No fertilisation 100
Fertilised, not transferred 87
Fertilised, transferred no pregnancy 90
Fertilised, transferred and pregnancy 68
TOTAL 345
Only fertilised oocytes that resulted in cleaved embryos were 
included in the 3 fertilised groups.
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8.2 FOLLICULAR FLUID CONCENTRATIONS OF PGE2 AND 
P G F 2a ACCORDING TO GROUP CATEGORY
Assays for PGE2 and PGF2c? were performed for all follicular fluids. 
Table 8 .B shows the median and range for PGE2.
TABLE 8 .B
FOLLICULAR FLUID PGE2 IN THE 4 STUDY GROUPS
MEDIAN RANGE N
ng/ml ng/ml
No fertilisation 2.41 0 .2 -3 6 .7  100
Fertilised, not transferred 3 .42  0 .3 -2 7 .8  87
Fertilised, transferred 2 .80  0 .4 -1 7 .9  90
no pregnancy
Fertilised, transferred, 2 .65  (ns) 0 .5 -6 5 .4  68
pregnancy
ns = not significant when compared by Non-parametric analysis 
(Mann-Whitney)
There was no significant difference in the follicular fluid PGE2 
concentration from oocytes that fertilised and those that did not. 
When the unfertilised group was compared with each of the three 
other fertilised groups individually, again no significant difference 
was shown.
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Although the range for PGE2 was much wider in the pregnancy 
group, the median was not statistically different.
The results for follicular fluid PGF2a are shown in table 8 .C.
TABLE 8 .C
FOLLICULAR FLUID PGF2a IN THE 4 STUDY GROUPS
MEDIAN RANGE N
ng/ml ng/ml
No fertilisation 2.05 0 . 1-21 .6 100
Fertilised, not transferred 2.11 0 .4 -9 5 .0 87
Fertilised, transferred 2.20 0 .1 5 -2 7 .6 90
no pregnancy
Fertilised, transferred, 1.85 (ns) 0 .6 -33 .7 68
pregnancy
ns =  not significant when compared by Non-parametric analysis 
(Mann-Whitney)
The results were not statistically different between the groups 
when PGF2ff levels were compared.
The actual concentrations of both prostaglandins therefore, shows 
no relationship with the various outcomes of the matched oocyte.
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However a highly significant correlation (p < 0 .0 0 1 ) was shown 
between follicular fluid PGE2 and PGF2a for all groups with the 
exception of the fertilised but not transferred group (Table 8 .D).
TABLE 8 .D
CORRELATION BETWEEN FOLLICULAR FLUID PGE2 
AND PGF2w FOR THE 4 STUDY GROUPS
£> r N
No fertilisation < 0 .0 0 1  0 .89  100
Fertilised, not transferred ns 0 .17  87
Fertilised, transferred < 0 .0 0 1  0 .69  90
no pregnancy
Fertilised, transferred < 0 .0 0 1  0 .88  68
The ratio of PGE2 to PGF2{y was calculated for all groups (Table 8 .E).
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TABLE 8.E
FOLLICULAR FLUID PGE2:PGF2t? RATIO FOR THE 4 STUDY  
GROUPS
MEDIAN RANGE
No fertilisation 
Fertilised, not transferred 
Fertilised, transferred
1.50
1.55
1.40
0 .1 8 -5 .5  100
0 .1 5 -7 .6 6  87
0 .3-5 .91  90
no pregnancy 
Fertilised, transferred, 1 . 1 0 * * *  0 .4 6 -2 .0 0  68
pregnancy
* * *  p < 0.001 when compared by Non-parametric analysis (Mann- 
Whitney) to the other 3 groups.
The PGE2:PGF2w ratio was not significantly different between the 
unfertilised group and the combined three fertilised groups. However 
when the unfertilised group was compared with the three fertilised groups 
individually, the 'pregnancy' group was the only group to show a 
significant difference and this difference was highly significant 
(p < 0 .001 ). This highly significant difference was also shown when the 
'pregnancy' group was compared to the fertilised, not transferred and 
most importantly to the fertilised, transferred, no pregnancy group.
The range for the ratio in the group that established pregnancy was much 
narrower, 0 .4 6 -2 .0 0  compared to the other three groups (no fertilisation, 
0 .18 -5 .5 ; fertilised not transferred, 0 .15 -7 .66 ; fertilised transferred, no 
pregnancy 0 .3 -5 .91 ). (Figure 8 .A).
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8.3 FOLLICULAR FLUID STEROID HORMONE CONCENTRATIONS 
ACCORDING TO GROUP CATEGORY
All follicular fluids were assayed for E2 and P. The median and range for 
follicular fluid E2 and P levels is shown in Table 8 .F.
There was no significant difference in follicular fluid E2 levels shown 
between the unfertilised group and the fertilised groups either together or 
individually.
However there was a significant difference in the follicular fluid P levels 
when no fertilisation was compared with fertilisation (p < 0 .0 0 5 ). When 
the fertilised groups were compared individually with the unfertilised 
group this signficance was only seen for the fertilised, tranferred, no 
pregnancy group. (p < 0 .0 0 1 )
There was a significant correlation shown between E2 and P ( p < 0 .001 ) in 
all groups except the fertilised, transferred, no pregnancy group (Table 
8 .G).
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TABLE 8.F
FOLLICULAR FLUID E2 AND P LEVELS AND THE E2:P RATIO FOR
THE 4 STUDY GROUPS
MEDIAN RANGE N 
NO FERTILISATION 100
E2 nmol/L 780  50 -35 00
P jt/mol/L 5 .95  1-31
E2:P (x 10'3) 120.5  20 -10 50
FERTILISED, NOT TRANSFERRED 87
E2 nmol/L 765 (ns) 62 -31 00
P/ymol/L 8 .2  1-33
E2:P ( x  10‘3) 81 .5  16-880
FERTILISED, TRANSFERRED, NO PREGNANCY 90
E2 nmol/L 845 (ns) 64 -4500
Pyi/mol/L 12.3 * * *  1-50
E2:P ( x  10'3) 78 2-549
FERTILISED, TRANSFERRED, PREGNANCY 68
E2 nmol/L 810 (ns) 11-3600
Pjt/mol/L 8 .4  (ns) 1-40
E2:P ( x  10'3) 1 15 4 -355
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney) to the no fertilisation group.
* * *  p < 0.001
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TABLE 8.G
CORRELATION BETWEEN FOLLICULAR FLUID E2 AND P
£> r N
No fertilisation < 0 .0 0 1  0 .56  100
Fertilised, not transferred < 0 .0 0 1  0 .56  87
Fertilised, transferred ns 0 .18  90
no pregnancy
Fertilised, transferred, < 0 .0 0 1  0 .52  68
pregnancy
There were no significant differences shown in any of the groups for the 
E2:P ratio (Table 8 .H).
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TABLE 8.H
FOLLICULAR FLUID E2:P RATIO
MEDIAN RANGE N
No fertilisation 
Fertilised, not transferred 
Fertilised, transferred
120.5 (ns) 2 0 -10 50  100
78 (ns) 1 .8 -549  87
81 .5  (ns) 16-880 90
no pregnancy 
Fertilised, transferred, 115 (ns) 4 -355 68
pregnancy
ns = not signficant when compared by Non-parametric analysis (Mann- 
Whitney).
There was a negative correlation shown between PGE2 or PGF2a and E2 
and also between PGE2 and P for the unfertilised group (See Table 8 .1). 
There were no correlations between the prostaglandins and the steroid 
hormones in the other groups.
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TABLE 8.1
CORRELATION BETWEEN FOLLICULAR FLUID PGE2 AND PGF2a 
W ITH E2 AND P IN THE 4 STUDY GROUPS
PGEo V Eo PGEo V P PGFor V Eo PGFor V  P
UNFERTILISED
p < 0 .0 0 5  p < 0 .0 5  p < 0 .0 1  p =  ns
r = -0 .29  r = -0.21 r = -0 .28  r = -0 .1 7
FERTILISED, NOT TRANSFERRED
p = ns p = ns p = ns p =  ns
r = 0 .006  r = 0 .08  r = 0 .09  r = 0 .0 6
FERTILISED, TRANSFERRED, NO PREGNANCY
p = ns p = ns p = ns p =  ns
r = 0 .17  r = 0 .13  r = 0 .13  r =  0.01
FERTILISED, TRANSFERRED, PREGNANCY
p = ns p = ns p = ns p =  ns
r = 0 .10  r = 0 .14  r = 0 .009  r = 0 .17
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney)
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8 .4  SUMMARY
The follicular fluid analysis of prostaglandins, PGE2 and PGF2w, oestradiol 
and progesterone on this more select group was able to substantiate some 
earlier findings. Results also showed further important statistical and 
probably biological significances.
The PGE2:PGF2o ratio values were generally lower and within "tighter" 
ranges than calculated previously (Chapter 5) as one might expect for this 
group. Therefore it was possible to show that the fertilised oocytes (not 
dependent on their embryo grade) associated with a pregnancy outcome 
had a significantly narrower range of PGE2:PGF2o ratio than those not 
associated with a pregnancy.
Interestingly the E2:P ratio for the 'pregnancy' group was also narrower 
but the difference from other groups did not reach statistical significance. 
In addition P levels in follicles associated with oocytes, that were fertilised 
but no pregnancy resulted, were significantly higher.
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CHAPTER 9
TOTAL PROTEIN CONTENT OF FOLLICULAR FLUID AND 
ANDROGEN CONCENTRATIONS
9.1 PROTEIN CONTENT OF FOLLICULAR FLUID
In order to substantiate the significant correlation between PGE2 
and PGF2a and likewise between E2 and P, protein concentrations 
were measured in three sample groups of follicular fluid: 
unfertilised; fertilised, transferred, no pregnancy; and transferred, 
fertilised and pregnancy.
Total protein concentration was measured by a standard Coomassie 
Brilliant Blue (CBB) method. This dye - binding method was 
originally described for cerebro-spinal fluid (Johnson & Lott, 1978) 
and subsequently adapted to urine (Lott, Stephen & Pritchard,
1983) CBB binds to protonated amine groups of amino acid 
residues in the polypeptide chain, and the absorbance maximum for 
the bound species of the dye decreases at 465nm  and increased at 
595nm .
Table 9 .A shows the range of protein concentrations found in a 
random selection of follicular fluids from the different groups. The 
range indicated that a few  samples had been diluted with flushing 
medium.
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TABLE 9 .A
RANGE OF PROTEIN CONCENTRATIONS
MODE(ma/ml) RANGE(mg/ml) n
Unfertilised 30.8 10.5-46 12
Fertilised, transferred 24 .8 3.8  - 50 15
no pregnancy 
Fertilised, transferred 33 (ns) 2 .7  - 45 .3 12
pregnancy
ns =  not significant when compared by Non-parametric analysis (Mann- 
Whitney).
>  90%  were above 20 mg/ml.
These findings are similar to those reported by Stone et al (1988). The 
median protein concentration in follicular fluid was 39mg/ml and no 
significant differences were shown between pregnant and non pregnant 
outcomes.
The PGE2: protein ratio and the PGF2ff;protein ratio were calculated. The 
summary of the prostag!andin:protein ratios is shown in Tables 9.B and 
9.C.
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TABLE 9.B
Dr EM
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FOLLICULAR FLUID PGE,:PROTEIN RATIO
MEDIAN RANGE N
Unfertilised 
Fertilised, transferred 
no pregnancy 
Fertilised, transferred 
pregnancy
0.56
0 .99
0 .1 3 -6 .4 3  12
0 .1 -1 3 .1 7  15
0.90(ns) 0 .2 2 -8 .5 2  12
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney).
TABLE 9.C
FOLLICULAR FLUID PGF2a:PROTEIN RATIO
MEDIAN RANGE N
Unfertilised 
Fertilised, transferred 
no pregnancy 
Fertilised, transferred 
pregnancy
0 .60
0.66
0 .1 4 -3 .9  12
0 .0 7 -9 .2 5  15
0.79(ns) 0 .2 5 -8 .8 9  12
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney).
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The same highly significant correlation found between PGE2 and PGF2a in 
follicular fluid was also shown between the PGE2:protein ratio and the 
PGF2w:protein ratio. (p cO .00 1 , r =  0.77) (Figure 9 .A)
A highly significant correlation was also shown between the E2: protein 
ratio and the P:protein ratio in follicular fluids (p < 0 .0 0 1 , r = 0 .69 ) (Figure
9.B). However, once again there were no significant correlations between 
the steroids and the prostaglandins.
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9.2  ANDROGEN CONCENTRATIONS IN FOLLICULAR FLUID
Many factors are involved in ensuring successful fertilisation, not least of 
which is the developmental state of the follicle at the time of aspiration. 
The cumulus-oocyte complex is exposed to the hormonal environment of 
the follicular fluid, where concentrations can vary quite dramatically in the 
pre-ovulatory follicle.
E2 and P content of follicular fluid have been analysed extensively in a 
preceding chapter. Follicular fluid analysis would not be complete without 
reference to androgen levels.
Steroidogenesis in the ovary and in particular th e A 5  pathway involved in 
the biosynthesis of androgens and oestrogens is shown in Diagram 9 .A.
The amount of androstenedione in follicular fluid changes during follicle 
growth. It is found in higher amounts than E2 in growing follicles but in 
smaller quantities in pre-ovulatory follicles (Edwards, 1980).
Fowler et al (1977), using the natural cycle, found higher levels of 
androstenedione in non-ovulatory follicles from which oocytes did not 
fertilise, compared to pre-ovulatory follicles. Pre-ovulatory follicles 
contained androstenedione levels in the range 3-107ng/m l compared to a 
range of 991 -2169  ng/ml in non-ovulatory follicles.
Fowler et al (1978), again demonstrated higher androgen levels in non­
ovulatory follicles from hMG stimulated cycles.
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DIAGRAM 9A STEROIDOGENESIS IN THE OVARY
CHOLESTEROLI
PREGNENOLONE
A4 PATHWAY A 5 PATHWAY1
PROGESTERONE
\
17 HYDROXY-A5-PREGNENOLONEI
17 HYDROXYPROGESTERONEI
TESTOSTERONE^— ►ANDROSTENEDIONE-* DEHYDROEPIANDROSTERONE
\
ESTRADIOL OESTRONE ANDROSTERONE EPIANDROSTERONE
o
Androstenedione
OH
Testosterone
Fishel et al (1983), showed no significant differences in androstenedione 
levels whether or not fertilisation of the oocyte occurred. The majority of 
fertilised oocytes had a follicular fluid androstenedione:E2 ratio of around 
0.1 . However ratios greater than 0.1 were compatible with fertilisation.
Lower androstenedione:E2 ratios were shown by both Chikhaoui et al 
(1983) and Chabab et al (1986) to be associated with a favourable 
outcome.
Chikhaoui et al using CC stimulated cycles showed an androstenedione:E2 
ratio less than or equal to 0 .5  to be associated with the highest 
fertilisation and cleavage rates.
Chabab et al analysed both CC and hMG stimulated cycles and found a 
ratio of less than 1.0  to be most favourable for fertilisation and pregnancy 
outcome.
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RESULTS
Androstenedione levels were assayed in a sample population from each of 
three follicular fluid groups: unfertilised; fertilised, transferred, no 
pregnancy; and fertilised, transferred, pregnancy.
Androstenedione was measured by a commercially available 
radioimmunoassay (Amersham, UK, Product No. IM B.500).
The main steps of the assay are:
Incubation of reaction mixture 
30 minutes in 37°C waterbath
then
Addition of precipitating reagent 
15 minutes incubation 
then 
Centrifuge 
then
Decantation of supernatant 
then 
Retain pellet 
then
Radioactivity counting in a gamma 
counter
The cross-reactivity was 4%  for 5o-Androstane-3,17-dione and less than 
3%  for other steroid hormones and their metabolites.
Sample/Standard 
+ tracer 
+ antiserum
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The intra-assay variation was 5% and the inter-assay variation was 6 %. 
The minimal detection concentration of androstenedione was 0.04ng/m l 
Ot/g/l).
Table 9.D shows the median and range for the androstenedione levels in 
these selected follicular fluids.
Figure 9.C displays the ranges for the three groups in histogram form.
TABLE 9.D
FOLLICULAR FLUID ANDROSTENEDIONE CONCENTRATIONS
MEDIAN RANGE N
//g/L /yg/L
Unfertilised 45 .5  3 .5 -503  12
Fertilised, transferred 35 .4  13 .8 -260  15
no pregnancy
Fertilised, transferred 34.1(ns) 8 .2 -87  12
pregnancy
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney).
Although there were no significant differences shown between the groups 
a tighter range for androstenedione was seen as the outcome became 
more favourable.
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FIGURE 9C1 RANGE OF ANDROSTENEDIONE IN UNFERTILISED GROUP
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Table 9.E shows the median and range for the androstenedioneiprotein
ratio in each group.
TABLE 9.E
FOLLICULAR FLUID ANDROSTENEDIONE:PROTEIN RATIO
MEDIAN RANGE N
Unfertilised 0.42 0 .0 9 -3 .8 6  12
Fertilised, transferred 0 .44 0 .2 1 -1 .2 4  15
no pregnancy
Fertilised, transferred 0.34(ns) 0 .2 5 -1 .5 7  12
pregnancy
ns =  not significant when compared by Non-parametric analysis (Mann- 
Whitney).
There was no significant difference in androstenedione levels between the 
groups. Once again results were not affected by taking into account the 
protein concentration and thus any dilution effect.
The unfertilised group contains isolated high levels and low levels of 
androstenedione which are not seen in either of the tw o fertilised groups. 
However no overall difference was found between any of the groups.
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Table 9.F shows the median and range for the androstenedione:E2 ratio in
the three groups. No significant difference was shown.
TABLE 9.F
THE FOLLICULAR FLUID ANDROSTENEDIONE:E2 RATIO
MEDIAN RANGE N
Unfertilised 0.03 0 .1 -0 .7 4  12
Fertilised, transferred 0 .04 0 .0 2 -0 .2 7  15
no pregnancy
Fertilised, transferred 0.04(ns) 0 .01-0 .41  12
pregnancy
ns = not significant when compared by Non-parametric analysis (Mann- 
Whitney).
The fertilised, no pregnancy group was the only group in which a 
significant correlation was found between androstenedione and E2. 
Androstenedione and progesterone were not significantly correlated in any 
of the groups. However, as previously shown, E2 correlated significantly 
with P in all groups. The prostaglandins did not show significant 
correlations with any of the steroids or ratios. Nevertheless the
prostaglandin ratio did once again show to be statistically different in the 
'pregnancy' group from the 'no pregnancy' group (p< 0 .0 1 ).
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9.3 SUMMARY
It was important to show that possible dilution effects with flushing 
medium were not causing some of the established relationships.
However, if dilution had occurred to a great extent, previous 
findings should have shown positive correlations between the 
prostaglandins and the steroids, when not allowing for protein 
effects. This was not found. The ratios between tw o variables 
(i.e. PGE2:PGF2a), of course, would not be affected.
Nevertheless, the significant correlation between PGE2 and PGF2w 
levels could be shown if the protein concentration was taken into 
consideration (Section 9.1) once again prostaglandins did not 
correlate with steroid levels.
Androstenedione was also measured in follicular fluid samples. The 
fertilised groups showed narrower ranges than the unfertilised 
group, but no statistical differences could be found. The fertilised 
groups also showed a narrower range for the androstenedione:E2 
ratio.
These data showed the presence of extreme biochemical levels in 
follicular fluids associated with poor outcome, but only with the 
prostaglandin ratio could important statistically significant results 
be obtained.
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CHAPTER 10
DISCUSSION
In vitro fertilisation is now a well established technique for the 
treatment of various forms of infertility. Nevertheless despite more 
than a decade's experience and major advances, success rates 
remain low.
Implantation of embryos transferred after IVF depends on several 
factors, many of which remain unclear. Sharma et al, (1988) 
showed the influence of the number of embryos transferred. The 
clinical pregnancy rate progressively increased from 8 .6 % when 
one embryo was transferred to 29 .5%  when four embryos were 
transferred. Jones et al, (1983) emphasized the importance of the 
endocrine characteristics of the transfer cycle. The highest 
pregnancy rates were obtained when the serum E2 continued to rise 
throughout the follicular phase and on the day following the 
administration of hCG. The value of E2 had usually fallen on the 
day of oocyte collection. Garcia et al, (1984) performed early 
luteal phase endometrial biopsies in patients whose embryo transfer 
was not accomplished. Serum levels in pregnancy cyles were 
compared with the serum P levels in these patients. It was 
concluded that since the embryo arrives in the endometrial cavity 
considerably earlier than in the natural cycle (approximately 52  
hours compared to 72-96 hours) "advanced" endometrium might 
be beneficial for implantation.
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These three factors, the number of embryos transferred, the 
endocrine characteristics of the transfer cycle and endometrial 
morphology at the time of transfer are known to influence the 
outcome of the IVF procedure. All three factors are inter-related 
and affected by the changing concentrations of various 
components of follicular fluid. The studies in this thesis attempted 
to establish whether differing components of follicular fluid, in 
particular prostaglandins and steroid hormones were associated 
with the degree of success and thus possibly "influenced" the 
outcome of oocytes fertilised in vitro. Success rates of embryo 
transfer would be improved substantially if only viable embryos 
could be selected for transfer. The follicular fluid results would be 
used together with the microscopic evaluation of the embryos to 
produce a more sensitive assessment of embryo viability.
Reliable assays for the steroid hormones to be measured had been 
well established, but prostaglandin assays at the start of these 
studies required careful assessment and refinement. Initially it was 
established that an extraction process was necessary prior to 
radioimmunoassay for PGE2 and PGF2c?. Previous workers had 
extracted prostaglandins using various organic solvents or by 
extensive chromatography on columns of XAD-2 resin (Chapter
1.4, Table 1.B). Extraction on ODS silica mini-columns proved to 
be a fast, convenient and moderately inexpensive method for the 
removal of PGE2 and PGF2w from follicular fluids. Recoveries varied 
between 80 and 95%  with this extraction method whereas without 
extraction no more than 58%  of PGE2 and PGF2o could be detected. 
(Chapter 4 .6 , Figures 4 .FI and 4 .1)
Dr EM Smith
Thesis 155 Chapter 10
Although prostaglandins are rapidly catabolised within the body, 
freeze storage of follicular fluid did not influence the results. The 
variation in results between assays on fresh samples and frozen 
samples did not exceed 7%  for PGE2 and 8 % for PGF2a. (Chapter 
4 .7 , Figures 4.J and 4.K) Radioimmunoassays for PGE2 and PGF2a 
on extracts were reliable and reproducible. The intra-assay 
coefficient of variations were 4%  and 5%  for PGE2 and PGF2a 
respectively and the inter-assay coefficient of variations were 7%  
and 8 % for PGE2 and PGF2ff respectively. (Chapter 4 .5) The 
steroid hormones were assayed in unextracted samples using 
commerical assays designed for direct determination of steroids.
In this thesis, preliminary studies measured E2 and P in follicular 
fluid and comparisons were made in regard to the presence or 
absence of an oocyte, fertilisation, cleavage and embryo grade. 
Many workers have measured the steroid hormones in human 
ovarian follicles and attempts have been made to correlate follicular 
fluid concentrations of these substances with these various 
outcomes. Literature results, however, have been conflicting. 
Higher E2 and P concentrations have been associated with oocyte 
containing follicles compared to follicles without oocytes (Tsuiki et 
al, 1988). This study did not confirm these findings. (Table 10 .A).
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TABLE 10. A
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FOLLICULAR FLUID E2 AND P LEVELS IN OOCYTE CONTAINING  
AND NON OOCYTE CONTAINING FOLLICLES
Oocyte
E2 nmol/L 
P //mol/L 
No Oocyte
E2 nmol/L 
P //mol/L 
Regime
SOTON = Southampton
* * *  p < 0.001
ns =  not significant
TSUIKI
Mean
1006 (444-2007)
6.9 (0 .42-22.9 )
7530  (9 6 5 -1 3 5 7 0 )* * *  
2 .28  (0 .0 2 8 -6 .2 5 )* * *  
CC/hMG or FSH
SOTON
Mean
634  (11-3400) 
12.72 (1 .5 -55)
526 (68-2300) (ns) 
12.58 (1 .5 -42) (ns) 
LHRH-A/hMG
Fishel et al (1983) and Botero-Ruiz et al (1984) showed that high 
fertilisation rates were associated with elevated follicular fluid E2 
concentrations whereas Reinthaller et al (1983) associated 
successful fertilisation with higher follicular fluid P concentrations. 
Lack of correlation between follicular fluid P or E2 concentrations 
and subsequent fertilisation has also been reported. (Berger et al, 
1987). No differences between E2 and P were shown in this study 
whether or not fertilisation occurred (Table 10.B).
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No significant differences in the steroid hormone levels were found 
when comparing fast and slow cleaving embryos (Chapter 5 .4 , 
Table 5.K) and good quality and poor quality embryos. (Chapter
5 .5 , Table 5.N). The steroid hormones, therefore did not appear to 
be potential markers of oocyte quality within the range of follicles 
assessed as optimal by transvaginal ultrasound in the present 
studies.
The prostaglandins, PGE2 and PGF2a, were also measured in the 
preliminary study and similar comparisons made. The involvement 
of prostaglandins in the process of ovulation has been established 
in animal studies. Yang et al (1974), Tsang et al (1979), Brown et 
al (1984) and Espey et al (1986) all showed significantly higher 
levels of both PGE2 and PGF2ff in follicles destined to ovulate. 
Ovulation in animals can be prevented by administering a cyclo- 
oxygenase inhibitor, such as indomethacin. Indomethacin blocked 
ovulation in rats (Tsafriri et al, 1972, Parr, 1975), monkeys 
(Wallach et al, 1975) and rabbits (Rhodes et al, 1985). Ovulation 
can also be prevented by administration of antisera to 
prostaglandins (Armstrong et al, 1974).
The role of follicular fluid prostaglandins in relation to the 
subsequent outcome of the associated oocyte and also whether the 
follicle yielded an oocyte has been studied in humans. The results 
have been inconsistent.
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Both Lumsden et al (1986) and Jeremy et al (1986) showed 
significantly higher concentrations of both prostaglandins, PGE2 and 
PGF2(7 when the follicle contained an oocyte. My study, in agreement 
with the findings of Heinonen et al (1986) did not show this 
difference. (Table 10.C) Comparison between fertilisation and non­
fertilisation also showed no significant differences for either PGE2 or 
PGF2a concentrations. This is in agreement with other studies (Table
10.D).
Similarly, prostaglandin concentrations did not differ significantly with 
differing rates of cleavage or embryo grade. The ratio of PGE2 to 
PGF2ct was not significantly different for any of the parameters 
analysed. Table 10.E summarises the results of the preliminary 
findings.
Dr EM Smith
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The wide disparity in previous study findings (Lumsden et al, 1986, 
Jeremy et al, 1986) and the results of my preliminary study could 
be explained in terms of lack of overall uniformity. The indications 
for IVF in their reports were quite diverse and a number of studies 
analysed small numbers of follicles from an even smaller number of 
patients. Ovarian hyperstimulation regimes were not standardised 
and consisted of either clomiphene citrate alone or in combination 
with hMG, hMG alone or FSH alone. No study was conducted on 
follicular fluids following a hyperstimulation regime which included 
an LHRH-A. Oocyte recoveries, in the main, were performed 
laparoscopically, thus subjecting the follicles to the influence of a 
prolonged C 0 2 pneumoperitoneum and also general anaesthesia. 
The methodology for the extraction of prostaglandins from follicular 
fluid differed widely (Chapter 1.4, Table 1 .B) as did the 
methodology for the various radioimmunoassays. Is it surprising 
therefore that there is disagreement in the literature?
The preliminary study had not shown any obvious significant 
differences in either prostaglandins or steroid hormone 
concentrations in follicular fluid when the various outcomes of the 
associated oocyte were analysed. A non-select group of patients 
had been studied and IVF practices were not standardised. 
Therefore, to control for such variability, a purer patient group with  
only mechanical indications for IVF and standardised IVF 
procedures was selected for the second, in depth study. The 
pregnancy rate for this select group was of high enough standard 
to be introduced as a further parameter for evaluation.
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All patients were hyperstimulated with the combination of the 
LHRH-A, buserelin and hMG. This regime increases the oocyte 
yield and prevents premature luteinisation (Chapter 2 .1). Cycles 
were monitored by transvaginal ultrasound resulting in more 
accurate cycle monitoring. All oocyte recoveries were performed 
using ultrasound guided transvaginal aspiration. Pregnancy rates of 
33%  per embryo transfer were achieved during the second year of 
the programme and this compared favourably with results from the 
best centres.
Firstly, serum concentrations of E2 and P were measured and 
comparisons made between the 'pregnancy' and the 'no 
pregnancy' groups. On luteal day + 1 , (day of hCG administration 
= day 0) no significant differences were shown. (Chapter 7 .2 , 
Table 7.B) However, narrower ranges for both E2 and P were found 
within the 'pregnancy' group. Isolated low and high level cases 
were within the 'no-pregnancy' group and accounted for the wider 
range within this group but they were not enough to cause a 
statistical difference from the 'pregnancy' group. The number of 
oocytes recovered and embryos transferred were comparable for 
the tw o groups. (Chapter 7 .2 , Table 7.D)
The pregnancy group again demonstrated narrower ranges for both 
E2 and P in the mid luteal phase (day + 6 ) but the differences were 
not statistically significant. (Chapter 7 .2 , Table 7.G) However, in 
the late luteal phase, day + 12 , the 'pregnancy' group displayed 
significantly higher P levels (p < 0 .001). (Chapter 7 .2 , Table 7.H)
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These findings are consistent with those of Muasher et al (1984) 
and Dlugi et al (1984) who showed that the mean E2 and P 
concentrations in the luteal phase behaved similarly in pregnant and 
non-pregnant cycles except at the latter part of the luteal phase 
(after day + 1 1 ), when placental hCG and possible other factors are 
exerting their effects on the corpus luteum, ovary and endometrium 
of pregnant patients.
These steroids were then measured in follicular fluid, the medium in 
which prostaglandins could also be measured, for indications of 
their influence on oocytes. Follicular fluids were assigned to one of 
four groups depending upon the outcome of the matched oocyte.
1. No fertilisation
2. Fertilisation, not transferred
3. Fertilisation, transfer, no pregnancy
4. Fertilisation, transfer, pregnancy
Similar findings to the preliminary study were found when the 
follicular fluid E2 concentrations were analysed. There were no 
differences shown between the no-fertilisation group and the 
fertilisation group taken either together or individually. In contrast 
to the findings of the preliminary study the follicular fluid P 
concentrations were significantly higher (p < 0 .0 0 5 ) when 
fertilisation was compared to no fertilisation. These findings agree 
with those of Fishel et al (1983), Reinthaller et al (1987) and 
Berger et al (1987) (Table 10.B). However, this difference was not 
consistent when the fertilisation groups were compared 
individually. (Chapter 8 .3 , Table 8 .F)
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Follicular fluid E2 and P levels and the E2:P ratio were not 
significantly different when 'pregnancy' was compared with 'no­
pregnancy'. Basuray et al (1988) found significantly higher P levels 
associated with pregnancy and consequently a significantly lower 
E2:P ratio (Table 10.F)
TABLE 10.F
FOLLICULAR FLUID E2 AND P CONCENTRATION AND THE E2:P 
RATIO IN CONCEPTION AND NON CONCEPTION
BASURAY
MEAN
SOTON
MEAN
Pregnancy 
E2 nmol/L 
P //mol/L 
E2:P (x 1CT3) 
No Pregnancy 
E2 nmol/L 
P //mol/L 
E?:P ( x  1 0 * 3 )
2000
30 .9
65
1809 (ns) 
17.1 *
106*
810
8.4
115
845 (ns) 
12.3 (ns) 
78 (ns)
Regime 
* p < 0 .0 5
ns = not significant
CC/hMG LHRH-A/hMG
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Higher androstenedione levels have been demonstrated in follicles 
from which oocytes did not fertilise, both in the natural cycle 
(Fowler et al, 1977) and in stimulated cycles (Fowler et al, 1978; 
Fishel et al, 1983 and Reinthaller et al, 1987). The present studies 
(Chapter 9.2) whilst showing a narrower range for androstenedione 
and the androstenedione:E2 ratio in the fertilisation group, did not 
show any significant difference when compared with the no­
fertilisation group. Similarly no significant differences were found 
when 'pregnancy' was compared with 'no-pregnancy'.
The study of follicular fluid prostaglandin levels yielded the most 
interesting findings. The results of the preliminary study were 
repeated when non-fertilisation was compared with fertilisation.
No significant differences were shown for either PGE2 or PGF2ff 
concentrations. (Chapter 8.2 , Tables 8 .B and 8 .C)
There was a highly significant correlation within three of the four 
groups (the fertilised, not transferred group being the exception) 
between PGE2 and PGF2a levels (p<  0 .001) and a highly significant 
correlation between E2 and P levels (p< 0 .001) (with the exception 
of the fertilised, transferred, no-pregnancy group), but the 
correlation between prostaglandins and steroids was poor.
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No studies to date had established a relationship between the 
concentrations of PGE2 and PGF2a and the outcome of the matched 
oocyte in terms of pregnancy. This study showed that the actual 
levels of the tw o prostaglandins did not differ significantly when 
any tw o groups were compared. However, the ratio of PGE2 to 
PGF2a does have a highly significant relationship with the outcome 
of the matched oocyte. Chabab et al (1986) found the PGE2:PGF2a 
ratio consistently >  1 in all stimulated cycles. But Chabab showed 
no statistical differences for the ratio when no fertilisation; 
fertilisation, no pregnancy and fertilisation, pregnancy were 
compared. (Table 10.G)
TABLE 10.G
FOLLICULAR FLUID PGE2:PGF2a RATIO
CHABAB SOTON
MEAN MEAN
No Fertilisation 1.77 1.44
Fertilisation no
transferred 1.57
Fertilisation transferred
no pregnancy 1.64
Fertilisation transferred
1.42
pregnancy 2 .42  (ns) 1.07 * * *
* * *  p < 0.001
ns = not significant
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The studies of Chabab et al (1986), included a large number of 
variables. Four different hyperstimulation regimes and the natural 
cycle were analysed and the prostaglandins were assayed in 
unextracted samples.
This study showed the PGE2:PGF2wa ratios were generally lower and 
within narrower ranges than calculated previously as one might 
expect for the select group of patients. The prostaglandin ratio for 
the 'pregnancy' group was significantly lower (p < 0 .0 0 1 ) than the 
ratio for all other groups and that included the fertilised, 
transferred, no pregnancy group. The range for the 'pregnancy' 
group was narrower (0.45 - 2 .00) compared to the fertilised, 
transferred, no-pregnancy group (0.3 - 5 .91), the fertilised, not 
transferred group (0.15 - 7 .66) and the no fertilisation group 
(0 .18 - 5.5). (Chapter 8 .2 , Figure 8 .A)
Therefore for oocytes that have the potential to establish a 
pregnancy there is a well defined range for the PGE2:PGF2a ratio. 
Follicular fluid prostaglandins appear to play a significant role in 
predicting the outcome of an oocyte, not in terms of specific 
concentrations of prostaglandins but in the ratio of one to the 
other, thus possibly providing an indicator for the selection of 
embryos with the optimal chance of establishing a pregnancy.
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CONCLUDING REMARKS
The main aim of this thesis was to establish whether measurement 
of the components of follicular fluid, in particular the 
prostaglandins, PGE2 and PGF2a was of value in the prediction of 
outcome of the matched oocyte. If that proved to be the case the 
results would be incorporated with microscopic evaluation of the 
embryos with the ultimate aim of improving the pregnancy rate of 
IVF.
The major finding of this thesis, that of the highly significant 
difference in the follicular fluid PGE2:PGF2<? ratio when pregnancy 
resulted from the matched oocyte, may represent a biochemical 
marker of maturity of the associated oocyte. (The PGF2a has to be 
high enough in relation to the PGE2 to signify maturity but not too 
high to suggest over maturity. It is likely that a switch to more 
PGF2a occurs at optimal maturity, after an initial rise in both PGE2 
and PGF2ff after hCG administration).
The action of prostaglandins is still unknown. Edwards (1980) 
wrote "Prostaglandins have an important although unclear role in 
pre-ovulatory follicles". He further remarked that it used to be 
believed that prostaglandins were intermediaries in the luteinisation 
of granulosa cells, although their role in steroidogenesis was far 
from clear. Prostaglandins stimulated a resumption of meiosis in 
follicles cultured in vitro and this effect was independent of 
changes in steroid biosynthesis. Thus prostaglandins may be 
involved in oocyte maturation.
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Certainly, prostaglandins are synthesised for a reaction at a 
particular moment in time. They are produced at the site of action 
and rapidly catabolised, not stored. Thus the range of the 
prostaglandin ratio found for the 'pregnancy' group reflects the 
"moment" when conditions are optimal within the follicle for the 
associated oocyte to go on to establish pregnancy. If the oocyte is 
recovered beyond this optimal time, because of the fast catabolism 
of prostaglandins, the ratio is no longer at the optimal level, and 
regardless of the microscopic evaluation of the resultant embryo, 
pregnancy will not be established.
The steroid hormones are produced for a considerable length of 
time, both before and after events. Catabolism is less rapid and 
therefore the levels and the ratio of the steroid hormones are not as 
sensitive markers as that of the prostaglandin ratio.
The prostaglandin levels found in the hyperstimulated cycle may 
not necessarily reflect the physiological situtation. Investigation of 
the natural cycle is difficult because of small numbers of follicles 
available for analysis. The success rate for IVF using the natural 
cycle for one particular group is encouraging, 22 .5%  reported by 
Foulot et al (1989), and may provide a means of comparing the 
natural with the hyperstimulated cycle if this level of success can 
be maintained.
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These studies have established the importance of the optimal 
PGE2:PGF2a ratio. The process of extraction and radioimmunoassay 
for prostaglandins has been improved in this thesis but it may be 
necessary to improve them further before they are incorporated in 
the process of embryo evaluation for that current IVF cycle. 
Preparation of samples and their extraction takes around 2 hours. 
Overnight incubation of standards and samples with tracer and 
antiserum is an integral part of the radioimmunoassay. Thus, 
although it is possible to complete the measurement of 
prostaglandins within the timescale between oocyte recovery and 
embryo transfer, development of a faster assay would make this 
more feasible. It's major value, however, may be realised for the 
evaluation of the large number of embryos in frozen storage prior to 
transfer. There again, the technical difficulties associated with the 
freezing and thawing of embryos will have to be overcome before 
the usefulness of selecting the very best embryos can be realised.
Finally, it is one matter to show a statistically significant result, it is 
another to see it as a biologically significant one. It is a further 
large step to convert it to a clinically useful application. This thesis 
takes a few  important small steps towards finding the best 
biochemical markers of oocyte quality in an IVF programme.
Dr EM Smith
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